JP2007230881A - Anti-fatigue composition - Google Patents
Anti-fatigue composition Download PDFInfo
- Publication number
- JP2007230881A JP2007230881A JP2006051355A JP2006051355A JP2007230881A JP 2007230881 A JP2007230881 A JP 2007230881A JP 2006051355 A JP2006051355 A JP 2006051355A JP 2006051355 A JP2006051355 A JP 2006051355A JP 2007230881 A JP2007230881 A JP 2007230881A
- Authority
- JP
- Japan
- Prior art keywords
- rice
- derived
- extract
- fatigue
- acid
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000000203 mixture Substances 0.000 title claims abstract description 67
- 230000002929 anti-fatigue Effects 0.000 title claims abstract description 46
- 235000007164 Oryza sativa Nutrition 0.000 claims abstract description 150
- 235000009566 rice Nutrition 0.000 claims abstract description 150
- BTCSSZJGUNDROE-UHFFFAOYSA-N gamma-aminobutyric acid Chemical compound NCCCC(O)=O BTCSSZJGUNDROE-UHFFFAOYSA-N 0.000 claims abstract description 109
- 239000000284 extract Substances 0.000 claims abstract description 65
- 229960003692 gamma aminobutyric acid Drugs 0.000 claims abstract description 55
- OGNSCSPNOLGXSM-UHFFFAOYSA-N (+/-)-DABA Natural products NCCC(N)C(O)=O OGNSCSPNOLGXSM-UHFFFAOYSA-N 0.000 claims abstract description 45
- 108090000765 processed proteins & peptides Proteins 0.000 claims abstract description 13
- 239000004480 active ingredient Substances 0.000 claims abstract description 8
- 241000209094 Oryza Species 0.000 claims abstract 28
- 150000002632 lipids Chemical class 0.000 claims description 15
- 150000001720 carbohydrates Chemical class 0.000 claims description 9
- 235000013325 dietary fiber Nutrition 0.000 claims description 9
- 235000021329 brown rice Nutrition 0.000 claims description 8
- 102000004196 processed proteins & peptides Human genes 0.000 claims description 8
- 102000004169 proteins and genes Human genes 0.000 claims description 6
- 108090000623 proteins and genes Proteins 0.000 claims description 6
- 208000019914 Mental Fatigue Diseases 0.000 abstract description 23
- 210000001161 mammalian embryo Anatomy 0.000 abstract description 4
- 231100000989 no adverse effect Toxicity 0.000 abstract 1
- 235000013311 vegetables Nutrition 0.000 abstract 1
- 240000007594 Oryza sativa Species 0.000 description 122
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 30
- -1 isopropyl ester Chemical class 0.000 description 19
- RYYVLZVUVIJVGH-UHFFFAOYSA-N caffeine Chemical compound CN1C(=O)N(C)C(=O)C2=C1N=CN2C RYYVLZVUVIJVGH-UHFFFAOYSA-N 0.000 description 18
- 230000000052 comparative effect Effects 0.000 description 16
- 239000012153 distilled water Substances 0.000 description 14
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 12
- 206010016256 fatigue Diseases 0.000 description 12
- 238000000034 method Methods 0.000 description 12
- 235000013305 food Nutrition 0.000 description 11
- 238000009472 formulation Methods 0.000 description 11
- 230000006870 function Effects 0.000 description 11
- VZSRBBMJRBPUNF-UHFFFAOYSA-N 2-(2,3-dihydro-1H-inden-2-ylamino)-N-[3-oxo-3-(2,4,6,7-tetrahydrotriazolo[4,5-c]pyridin-5-yl)propyl]pyrimidine-5-carboxamide Chemical compound C1C(CC2=CC=CC=C12)NC1=NC=C(C=N1)C(=O)NCCC(N1CC2=C(CC1)NN=N2)=O VZSRBBMJRBPUNF-UHFFFAOYSA-N 0.000 description 10
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 10
- LPHGQDQBBGAPDZ-UHFFFAOYSA-N Isocaffeine Natural products CN1C(=O)N(C)C(=O)C2=C1N(C)C=N2 LPHGQDQBBGAPDZ-UHFFFAOYSA-N 0.000 description 9
- AFCARXCZXQIEQB-UHFFFAOYSA-N N-[3-oxo-3-(2,4,6,7-tetrahydrotriazolo[4,5-c]pyridin-5-yl)propyl]-2-[[3-(trifluoromethoxy)phenyl]methylamino]pyrimidine-5-carboxamide Chemical compound O=C(CCNC(=O)C=1C=NC(=NC=1)NCC1=CC(=CC=C1)OC(F)(F)F)N1CC2=C(CC1)NN=N2 AFCARXCZXQIEQB-UHFFFAOYSA-N 0.000 description 9
- 229960001948 caffeine Drugs 0.000 description 9
- VJEONQKOZGKCAK-UHFFFAOYSA-N caffeine Natural products CN1C(=O)N(C)C(=O)C2=C1C=CN2C VJEONQKOZGKCAK-UHFFFAOYSA-N 0.000 description 9
- YLZOPXRUQYQQID-UHFFFAOYSA-N 3-(2,4,6,7-tetrahydrotriazolo[4,5-c]pyridin-5-yl)-1-[4-[2-[[3-(trifluoromethoxy)phenyl]methylamino]pyrimidin-5-yl]piperazin-1-yl]propan-1-one Chemical compound N1N=NC=2CN(CCC=21)CCC(=O)N1CCN(CC1)C=1C=NC(=NC=1)NCC1=CC(=CC=C1)OC(F)(F)F YLZOPXRUQYQQID-UHFFFAOYSA-N 0.000 description 8
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 8
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 8
- 208000006011 Stroke Diseases 0.000 description 8
- 239000003153 chemical reaction reagent Substances 0.000 description 8
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 description 8
- 239000003921 oil Substances 0.000 description 8
- 235000019198 oils Nutrition 0.000 description 8
- 238000011084 recovery Methods 0.000 description 8
- 235000000346 sugar Nutrition 0.000 description 8
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 7
- 241000699670 Mus sp. Species 0.000 description 7
- 229940124277 aminobutyric acid Drugs 0.000 description 7
- 235000014113 dietary fatty acids Nutrition 0.000 description 7
- 239000000194 fatty acid Substances 0.000 description 7
- 229930195729 fatty acid Natural products 0.000 description 7
- 239000008103 glucose Substances 0.000 description 7
- 239000000843 powder Substances 0.000 description 7
- 230000009182 swimming Effects 0.000 description 7
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 6
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 6
- 229930006000 Sucrose Natural products 0.000 description 6
- 235000001014 amino acid Nutrition 0.000 description 6
- 150000001413 amino acids Chemical class 0.000 description 6
- 230000001939 inductive effect Effects 0.000 description 6
- 239000008101 lactose Substances 0.000 description 6
- 239000000463 material Substances 0.000 description 6
- 239000005720 sucrose Substances 0.000 description 6
- 239000003826 tablet Substances 0.000 description 6
- 108010010803 Gelatin Proteins 0.000 description 5
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 5
- 229920002472 Starch Polymers 0.000 description 5
- 239000002253 acid Substances 0.000 description 5
- 239000008273 gelatin Substances 0.000 description 5
- 229920000159 gelatin Polymers 0.000 description 5
- 235000019322 gelatine Nutrition 0.000 description 5
- 235000011852 gelatine desserts Nutrition 0.000 description 5
- 235000011187 glycerol Nutrition 0.000 description 5
- 239000007788 liquid Substances 0.000 description 5
- 235000018102 proteins Nutrition 0.000 description 5
- 239000000243 solution Substances 0.000 description 5
- 239000008107 starch Substances 0.000 description 5
- 235000019698 starch Nutrition 0.000 description 5
- GUBGYTABKSRVRQ-XLOQQCSPSA-N Alpha-Lactose Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)O[C@H](O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-XLOQQCSPSA-N 0.000 description 4
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 4
- VTYYLEPIZMXCLO-UHFFFAOYSA-L Calcium carbonate Chemical compound [Ca+2].[O-]C([O-])=O VTYYLEPIZMXCLO-UHFFFAOYSA-L 0.000 description 4
- WHUUTDBJXJRKMK-UHFFFAOYSA-N Glutamic acid Natural products OC(=O)C(N)CCC(O)=O WHUUTDBJXJRKMK-UHFFFAOYSA-N 0.000 description 4
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 4
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 4
- NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical compound OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 description 4
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 4
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 4
- 229960000583 acetic acid Drugs 0.000 description 4
- 210000004556 brain Anatomy 0.000 description 4
- 239000001913 cellulose Substances 0.000 description 4
- 235000015165 citric acid Nutrition 0.000 description 4
- 235000009508 confectionery Nutrition 0.000 description 4
- GVJHHUAWPYXKBD-UHFFFAOYSA-N d-alpha-tocopherol Natural products OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 description 4
- 238000005238 degreasing Methods 0.000 description 4
- 239000003814 drug Substances 0.000 description 4
- 235000013922 glutamic acid Nutrition 0.000 description 4
- 239000004220 glutamic acid Substances 0.000 description 4
- 239000008187 granular material Substances 0.000 description 4
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 4
- 238000004519 manufacturing process Methods 0.000 description 4
- 235000013336 milk Nutrition 0.000 description 4
- 239000008267 milk Substances 0.000 description 4
- 210000004080 milk Anatomy 0.000 description 4
- 229910052757 nitrogen Inorganic materials 0.000 description 4
- 150000007524 organic acids Chemical class 0.000 description 4
- 238000012360 testing method Methods 0.000 description 4
- BJEPYKJPYRNKOW-REOHCLBHSA-N (S)-malic acid Chemical compound OC(=O)[C@@H](O)CC(O)=O BJEPYKJPYRNKOW-REOHCLBHSA-N 0.000 description 3
- GJJVAFUKOBZPCB-UHFFFAOYSA-N 2-methyl-2-(4,8,12-trimethyltrideca-3,7,11-trienyl)-3,4-dihydrochromen-6-ol Chemical compound OC1=CC=C2OC(CCC=C(C)CCC=C(C)CCC=C(C)C)(C)CCC2=C1 GJJVAFUKOBZPCB-UHFFFAOYSA-N 0.000 description 3
- 244000215068 Acacia senegal Species 0.000 description 3
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 3
- 229920001817 Agar Polymers 0.000 description 3
- 239000005995 Aluminium silicate Substances 0.000 description 3
- 229920001661 Chitosan Polymers 0.000 description 3
- 240000008620 Fagopyrum esculentum Species 0.000 description 3
- 235000009419 Fagopyrum esculentum Nutrition 0.000 description 3
- 229920000084 Gum arabic Polymers 0.000 description 3
- KWYUFKZDYYNOTN-UHFFFAOYSA-M Potassium hydroxide Chemical compound [OH-].[K+] KWYUFKZDYYNOTN-UHFFFAOYSA-M 0.000 description 3
- 244000178231 Rosmarinus officinalis Species 0.000 description 3
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 3
- 244000269722 Thea sinensis Species 0.000 description 3
- 244000299461 Theobroma cacao Species 0.000 description 3
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 description 3
- 244000273928 Zingiber officinale Species 0.000 description 3
- 235000006886 Zingiber officinale Nutrition 0.000 description 3
- 235000010489 acacia gum Nutrition 0.000 description 3
- 239000000205 acacia gum Substances 0.000 description 3
- 239000008272 agar Substances 0.000 description 3
- 235000010419 agar Nutrition 0.000 description 3
- BJEPYKJPYRNKOW-UHFFFAOYSA-N alpha-hydroxysuccinic acid Natural products OC(=O)C(O)CC(O)=O BJEPYKJPYRNKOW-UHFFFAOYSA-N 0.000 description 3
- 235000012211 aluminium silicate Nutrition 0.000 description 3
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 3
- 235000013361 beverage Nutrition 0.000 description 3
- 230000036772 blood pressure Effects 0.000 description 3
- 235000010980 cellulose Nutrition 0.000 description 3
- 229920002678 cellulose Polymers 0.000 description 3
- 239000003795 chemical substances by application Substances 0.000 description 3
- 235000013353 coffee beverage Nutrition 0.000 description 3
- 230000000694 effects Effects 0.000 description 3
- 239000003995 emulsifying agent Substances 0.000 description 3
- 238000000605 extraction Methods 0.000 description 3
- 239000003205 fragrance Substances 0.000 description 3
- 235000008397 ginger Nutrition 0.000 description 3
- 235000013402 health food Nutrition 0.000 description 3
- NLYAJNPCOHFWQQ-UHFFFAOYSA-N kaolin Chemical compound O.O.O=[Al]O[Si](=O)O[Si](=O)O[Al]=O NLYAJNPCOHFWQQ-UHFFFAOYSA-N 0.000 description 3
- 239000001630 malic acid Substances 0.000 description 3
- 235000011090 malic acid Nutrition 0.000 description 3
- 235000013372 meat Nutrition 0.000 description 3
- 150000007522 mineralic acids Chemical class 0.000 description 3
- 238000002156 mixing Methods 0.000 description 3
- 238000002360 preparation method Methods 0.000 description 3
- 239000002994 raw material Substances 0.000 description 3
- 239000002904 solvent Substances 0.000 description 3
- 229930003802 tocotrienol Natural products 0.000 description 3
- 239000011731 tocotrienol Substances 0.000 description 3
- 235000019148 tocotrienols Nutrition 0.000 description 3
- YBJHBAHKTGYVGT-ZKWXMUAHSA-N (+)-Biotin Chemical compound N1C(=O)N[C@@H]2[C@H](CCCCC(=O)O)SC[C@@H]21 YBJHBAHKTGYVGT-ZKWXMUAHSA-N 0.000 description 2
- PFTAWBLQPZVEMU-DZGCQCFKSA-N (+)-catechin Chemical compound C1([C@H]2OC3=CC(O)=CC(O)=C3C[C@@H]2O)=CC=C(O)C(O)=C1 PFTAWBLQPZVEMU-DZGCQCFKSA-N 0.000 description 2
- GHOKWGTUZJEAQD-ZETCQYMHSA-N (D)-(+)-Pantothenic acid Chemical compound OCC(C)(C)[C@@H](O)C(=O)NCCC(O)=O GHOKWGTUZJEAQD-ZETCQYMHSA-N 0.000 description 2
- OWEGMIWEEQEYGQ-UHFFFAOYSA-N 100676-05-9 Natural products OC1C(O)C(O)C(CO)OC1OCC1C(O)C(O)C(O)C(OC2C(OC(O)C(O)C2O)CO)O1 OWEGMIWEEQEYGQ-UHFFFAOYSA-N 0.000 description 2
- MSWZFWKMSRAUBD-IVMDWMLBSA-N 2-amino-2-deoxy-D-glucopyranose Chemical compound N[C@H]1C(O)O[C@H](CO)[C@@H](O)[C@@H]1O MSWZFWKMSRAUBD-IVMDWMLBSA-N 0.000 description 2
- 241000894006 Bacteria Species 0.000 description 2
- CURLTUGMZLYLDI-UHFFFAOYSA-N Carbon dioxide Chemical compound O=C=O CURLTUGMZLYLDI-UHFFFAOYSA-N 0.000 description 2
- 240000003538 Chamaemelum nobile Species 0.000 description 2
- 235000007866 Chamaemelum nobile Nutrition 0.000 description 2
- 229920002567 Chondroitin Polymers 0.000 description 2
- 241000951471 Citrus junos Species 0.000 description 2
- ACTIUHUUMQJHFO-UHFFFAOYSA-N Coenzym Q10 Natural products COC1=C(OC)C(=O)C(CC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)C)=C(C)C1=O ACTIUHUUMQJHFO-UHFFFAOYSA-N 0.000 description 2
- 102000008186 Collagen Human genes 0.000 description 2
- 108010035532 Collagen Proteins 0.000 description 2
- 235000009917 Crataegus X brevipes Nutrition 0.000 description 2
- 235000013204 Crataegus X haemacarpa Nutrition 0.000 description 2
- 235000009685 Crataegus X maligna Nutrition 0.000 description 2
- 235000009444 Crataegus X rubrocarnea Nutrition 0.000 description 2
- 235000009486 Crataegus bullatus Nutrition 0.000 description 2
- 235000017181 Crataegus chrysocarpa Nutrition 0.000 description 2
- 235000009682 Crataegus limnophila Nutrition 0.000 description 2
- 240000000171 Crataegus monogyna Species 0.000 description 2
- 235000004423 Crataegus monogyna Nutrition 0.000 description 2
- 235000002313 Crataegus paludosa Nutrition 0.000 description 2
- 235000009840 Crataegus x incaedua Nutrition 0.000 description 2
- 235000003392 Curcuma domestica Nutrition 0.000 description 2
- 244000008991 Curcuma longa Species 0.000 description 2
- 235000002767 Daucus carota Nutrition 0.000 description 2
- 244000000626 Daucus carota Species 0.000 description 2
- 229930091371 Fructose Natural products 0.000 description 2
- 239000005715 Fructose Substances 0.000 description 2
- RFSUNEUAIZKAJO-ARQDHWQXSA-N Fructose Chemical compound OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O RFSUNEUAIZKAJO-ARQDHWQXSA-N 0.000 description 2
- 241000222336 Ganoderma Species 0.000 description 2
- DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 description 2
- 240000004670 Glycyrrhiza echinata Species 0.000 description 2
- 235000001453 Glycyrrhiza echinata Nutrition 0.000 description 2
- 235000006200 Glycyrrhiza glabra Nutrition 0.000 description 2
- 235000017382 Glycyrrhiza lepidota Nutrition 0.000 description 2
- 235000007340 Hordeum vulgare Nutrition 0.000 description 2
- 240000005979 Hordeum vulgare Species 0.000 description 2
- 102000010445 Lactoferrin Human genes 0.000 description 2
- 108010063045 Lactoferrin Proteins 0.000 description 2
- GUBGYTABKSRVRQ-PICCSMPSSA-N Maltose Natural products O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@@H](CO)OC(O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-PICCSMPSSA-N 0.000 description 2
- 235000007232 Matricaria chamomilla Nutrition 0.000 description 2
- 241001465754 Metazoa Species 0.000 description 2
- 240000005561 Musa balbisiana Species 0.000 description 2
- 244000183278 Nephelium litchi Species 0.000 description 2
- PVNIIMVLHYAWGP-UHFFFAOYSA-N Niacin Chemical compound OC(=O)C1=CC=CN=C1 PVNIIMVLHYAWGP-UHFFFAOYSA-N 0.000 description 2
- DFPAKSUCGFBDDF-UHFFFAOYSA-N Nicotinamide Chemical compound NC(=O)C1=CC=CN=C1 DFPAKSUCGFBDDF-UHFFFAOYSA-N 0.000 description 2
- 241000237502 Ostreidae Species 0.000 description 2
- 244000134552 Plantago ovata Species 0.000 description 2
- 235000003421 Plantago ovata Nutrition 0.000 description 2
- 239000009223 Psyllium Substances 0.000 description 2
- 240000004808 Saccharomyces cerevisiae Species 0.000 description 2
- 235000014680 Saccharomyces cerevisiae Nutrition 0.000 description 2
- CDBYLPFSWZWCQE-UHFFFAOYSA-L Sodium Carbonate Chemical compound [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 description 2
- UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical compound [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 description 2
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 2
- DBMJMQXJHONAFJ-UHFFFAOYSA-M Sodium laurylsulphate Chemical compound [Na+].CCCCCCCCCCCCOS([O-])(=O)=O DBMJMQXJHONAFJ-UHFFFAOYSA-M 0.000 description 2
- 238000010521 absorption reaction Methods 0.000 description 2
- 230000002378 acidificating effect Effects 0.000 description 2
- 229910000147 aluminium phosphate Inorganic materials 0.000 description 2
- 239000003963 antioxidant agent Substances 0.000 description 2
- 235000006708 antioxidants Nutrition 0.000 description 2
- 239000002585 base Substances 0.000 description 2
- MSWZFWKMSRAUBD-UHFFFAOYSA-N beta-D-galactosamine Natural products NC1C(O)OC(CO)C(O)C1O MSWZFWKMSRAUBD-UHFFFAOYSA-N 0.000 description 2
- GUBGYTABKSRVRQ-QUYVBRFLSA-N beta-maltose Chemical compound OC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O)[C@H](O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@@H]1O GUBGYTABKSRVRQ-QUYVBRFLSA-N 0.000 description 2
- VBICKXHEKHSIBG-UHFFFAOYSA-N beta-monoglyceryl stearate Natural products CCCCCCCCCCCCCCCCCC(=O)OCC(O)CO VBICKXHEKHSIBG-UHFFFAOYSA-N 0.000 description 2
- 239000011230 binding agent Substances 0.000 description 2
- 229910000019 calcium carbonate Inorganic materials 0.000 description 2
- 235000010216 calcium carbonate Nutrition 0.000 description 2
- YKPUWZUDDOIDPM-SOFGYWHQSA-N capsaicin Chemical compound COC1=CC(CNC(=O)CCCC\C=C\C(C)C)=CC=C1O YKPUWZUDDOIDPM-SOFGYWHQSA-N 0.000 description 2
- 235000014633 carbohydrates Nutrition 0.000 description 2
- 235000010418 carrageenan Nutrition 0.000 description 2
- 239000000679 carrageenan Substances 0.000 description 2
- 229920001525 carrageenan Polymers 0.000 description 2
- 229940113118 carrageenan Drugs 0.000 description 2
- 235000005487 catechin Nutrition 0.000 description 2
- ADRVNXBAWSRFAJ-UHFFFAOYSA-N catechin Natural products OC1Cc2cc(O)cc(O)c2OC1c3ccc(O)c(O)c3 ADRVNXBAWSRFAJ-UHFFFAOYSA-N 0.000 description 2
- 208000026106 cerebrovascular disease Diseases 0.000 description 2
- 235000019219 chocolate Nutrition 0.000 description 2
- DLGJWSVWTWEWBJ-HGGSSLSASA-N chondroitin Chemical compound CC(O)=N[C@@H]1[C@H](O)O[C@H](CO)[C@H](O)[C@@H]1OC1[C@H](O)[C@H](O)C=C(C(O)=O)O1 DLGJWSVWTWEWBJ-HGGSSLSASA-N 0.000 description 2
- 229950001002 cianidanol Drugs 0.000 description 2
- 235000019868 cocoa butter Nutrition 0.000 description 2
- 229940110456 cocoa butter Drugs 0.000 description 2
- 235000017471 coenzyme Q10 Nutrition 0.000 description 2
- ACTIUHUUMQJHFO-UPTCCGCDSA-N coenzyme Q10 Chemical compound COC1=C(OC)C(=O)C(C\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CCC=C(C)C)=C(C)C1=O ACTIUHUUMQJHFO-UPTCCGCDSA-N 0.000 description 2
- 229920001436 collagen Polymers 0.000 description 2
- 238000013329 compounding Methods 0.000 description 2
- 239000002537 cosmetic Substances 0.000 description 2
- 235000003373 curcuma longa Nutrition 0.000 description 2
- 230000001419 dependent effect Effects 0.000 description 2
- 229940079593 drug Drugs 0.000 description 2
- 235000018927 edible plant Nutrition 0.000 description 2
- 239000008157 edible vegetable oil Substances 0.000 description 2
- 235000013861 fat-free Nutrition 0.000 description 2
- OVBPIULPVIDEAO-LBPRGKRZSA-N folic acid Chemical compound C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)N[C@@H](CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-LBPRGKRZSA-N 0.000 description 2
- 239000005417 food ingredient Substances 0.000 description 2
- 235000011194 food seasoning agent Nutrition 0.000 description 2
- 235000021588 free fatty acids Nutrition 0.000 description 2
- 239000012362 glacial acetic acid Substances 0.000 description 2
- 229960002442 glucosamine Drugs 0.000 description 2
- 238000000227 grinding Methods 0.000 description 2
- 238000004128 high performance liquid chromatography Methods 0.000 description 2
- 238000007654 immersion Methods 0.000 description 2
- 230000002401 inhibitory effect Effects 0.000 description 2
- 238000004255 ion exchange chromatography Methods 0.000 description 2
- 229910052742 iron Inorganic materials 0.000 description 2
- 229960003284 iron Drugs 0.000 description 2
- CSSYQJWUGATIHM-IKGCZBKSSA-N l-phenylalanyl-l-lysyl-l-cysteinyl-l-arginyl-l-arginyl-l-tryptophyl-l-glutaminyl-l-tryptophyl-l-arginyl-l-methionyl-l-lysyl-l-lysyl-l-leucylglycyl-l-alanyl-l-prolyl-l-seryl-l-isoleucyl-l-threonyl-l-cysteinyl-l-valyl-l-arginyl-l-arginyl-l-alanyl-l-phenylal Chemical compound C([C@H](N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CO)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CS)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](C)C(=O)N[C@@H](CC=1C=CC=CC=1)C(O)=O)C1=CC=CC=C1 CSSYQJWUGATIHM-IKGCZBKSSA-N 0.000 description 2
- 239000004310 lactic acid Substances 0.000 description 2
- 235000014655 lactic acid Nutrition 0.000 description 2
- 229940078795 lactoferrin Drugs 0.000 description 2
- 235000021242 lactoferrin Nutrition 0.000 description 2
- 229940010454 licorice Drugs 0.000 description 2
- 238000005259 measurement Methods 0.000 description 2
- 229960003512 nicotinic acid Drugs 0.000 description 2
- 235000001968 nicotinic acid Nutrition 0.000 description 2
- 239000011664 nicotinic acid Substances 0.000 description 2
- 231100000957 no side effect Toxicity 0.000 description 2
- CNNRPFQICPFDPO-UHFFFAOYSA-N octacosan-1-ol Chemical compound CCCCCCCCCCCCCCCCCCCCCCCCCCCCO CNNRPFQICPFDPO-UHFFFAOYSA-N 0.000 description 2
- 229920001542 oligosaccharide Polymers 0.000 description 2
- 150000002482 oligosaccharides Chemical class 0.000 description 2
- 235000020636 oyster Nutrition 0.000 description 2
- 239000001814 pectin Substances 0.000 description 2
- 235000010987 pectin Nutrition 0.000 description 2
- 229920001277 pectin Polymers 0.000 description 2
- 239000002304 perfume Substances 0.000 description 2
- 239000008194 pharmaceutical composition Substances 0.000 description 2
- 239000000047 product Substances 0.000 description 2
- 229940070687 psyllium Drugs 0.000 description 2
- 239000008213 purified water Substances 0.000 description 2
- 238000010992 reflux Methods 0.000 description 2
- 229940109850 royal jelly Drugs 0.000 description 2
- 235000002020 sage Nutrition 0.000 description 2
- 235000002639 sodium chloride Nutrition 0.000 description 2
- 235000019333 sodium laurylsulphate Nutrition 0.000 description 2
- 239000007901 soft capsule Substances 0.000 description 2
- 235000021055 solid food Nutrition 0.000 description 2
- 239000010902 straw Substances 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- KDYFGRWQOYBRFD-UHFFFAOYSA-N succinic acid Chemical compound OC(=O)CCC(O)=O KDYFGRWQOYBRFD-UHFFFAOYSA-N 0.000 description 2
- 208000024891 symptom Diseases 0.000 description 2
- XOAAWQZATWQOTB-UHFFFAOYSA-N taurine Chemical compound NCCS(O)(=O)=O XOAAWQZATWQOTB-UHFFFAOYSA-N 0.000 description 2
- 235000013616 tea Nutrition 0.000 description 2
- KBPHJBAIARWVSC-XQIHNALSSA-N trans-lutein Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CC(O)CC1(C)C)C=CC=C(/C)C=CC2C(=CC(O)CC2(C)C)C KBPHJBAIARWVSC-XQIHNALSSA-N 0.000 description 2
- LWIHDJKSTIGBAC-UHFFFAOYSA-K tripotassium phosphate Chemical compound [K+].[K+].[K+].[O-]P([O-])([O-])=O LWIHDJKSTIGBAC-UHFFFAOYSA-K 0.000 description 2
- 235000013976 turmeric Nutrition 0.000 description 2
- 229940088594 vitamin Drugs 0.000 description 2
- 229930003231 vitamin Natural products 0.000 description 2
- 235000013343 vitamin Nutrition 0.000 description 2
- 239000011782 vitamin Substances 0.000 description 2
- 150000003722 vitamin derivatives Chemical class 0.000 description 2
- 235000013618 yogurt Nutrition 0.000 description 2
- 239000011701 zinc Substances 0.000 description 2
- 229910052725 zinc Inorganic materials 0.000 description 2
- UHVMMEOXYDMDKI-JKYCWFKZSA-L zinc;1-(5-cyanopyridin-2-yl)-3-[(1s,2s)-2-(6-fluoro-2-hydroxy-3-propanoylphenyl)cyclopropyl]urea;diacetate Chemical compound [Zn+2].CC([O-])=O.CC([O-])=O.CCC(=O)C1=CC=C(F)C([C@H]2[C@H](C2)NC(=O)NC=2N=CC(=CC=2)C#N)=C1O UHVMMEOXYDMDKI-JKYCWFKZSA-L 0.000 description 2
- GVJHHUAWPYXKBD-IEOSBIPESA-N α-tocopherol Chemical compound OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-IEOSBIPESA-N 0.000 description 2
- HDTRYLNUVZCQOY-UHFFFAOYSA-N α-D-glucopyranosyl-α-D-glucopyranoside Natural products OC1C(O)C(O)C(CO)OC1OC1C(O)C(O)C(O)C(CO)O1 HDTRYLNUVZCQOY-UHFFFAOYSA-N 0.000 description 1
- PEYUIKBAABKQKQ-AFHBHXEDSA-N (+)-sesamin Chemical compound C1=C2OCOC2=CC([C@H]2OC[C@H]3[C@@H]2CO[C@@H]3C2=CC=C3OCOC3=C2)=C1 PEYUIKBAABKQKQ-AFHBHXEDSA-N 0.000 description 1
- JQWAHKMIYCERGA-UHFFFAOYSA-N (2-nonanoyloxy-3-octadeca-9,12-dienoyloxypropoxy)-[2-(trimethylazaniumyl)ethyl]phosphinate Chemical compound CCCCCCCCC(=O)OC(COP([O-])(=O)CC[N+](C)(C)C)COC(=O)CCCCCCCC=CCC=CCCCCC JQWAHKMIYCERGA-UHFFFAOYSA-N 0.000 description 1
- KIUKXJAPPMFGSW-DNGZLQJQSA-N (2S,3S,4S,5R,6R)-6-[(2S,3R,4R,5S,6R)-3-Acetamido-2-[(2S,3S,4R,5R,6R)-6-[(2R,3R,4R,5S,6R)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2-carboxylic acid Chemical compound CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 KIUKXJAPPMFGSW-DNGZLQJQSA-N 0.000 description 1
- OMDQUFIYNPYJFM-XKDAHURESA-N (2r,3r,4s,5r,6s)-2-(hydroxymethyl)-6-[[(2r,3s,4r,5s,6r)-4,5,6-trihydroxy-3-[(2s,3s,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoxan-2-yl]methoxy]oxane-3,4,5-triol Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@@H]1OC[C@@H]1[C@@H](O[C@H]2[C@H]([C@@H](O)[C@H](O)[C@@H](CO)O2)O)[C@H](O)[C@H](O)[C@H](O)O1 OMDQUFIYNPYJFM-XKDAHURESA-N 0.000 description 1
- PJVXUVWGSCCGHT-ZPYZYFCMSA-N (2r,3s,4r,5r)-2,3,4,5,6-pentahydroxyhexanal;(3s,4r,5r)-1,3,4,5,6-pentahydroxyhexan-2-one Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C=O.OC[C@@H](O)[C@@H](O)[C@H](O)C(=O)CO PJVXUVWGSCCGHT-ZPYZYFCMSA-N 0.000 description 1
- JKQXZKUSFCKOGQ-JLGXGRJMSA-N (3R,3'R)-beta,beta-carotene-3,3'-diol Chemical compound C([C@H](O)CC=1C)C(C)(C)C=1/C=C/C(/C)=C/C=C/C(/C)=C/C=C/C=C(C)C=CC=C(C)C=CC1=C(C)C[C@@H](O)CC1(C)C JKQXZKUSFCKOGQ-JLGXGRJMSA-N 0.000 description 1
- DNXIKVLOVZVMQF-UHFFFAOYSA-N (3beta,16beta,17alpha,18beta,20alpha)-17-hydroxy-11-methoxy-18-[(3,4,5-trimethoxybenzoyl)oxy]-yohimban-16-carboxylic acid, methyl ester Natural products C1C2CN3CCC(C4=CC=C(OC)C=C4N4)=C4C3CC2C(C(=O)OC)C(O)C1OC(=O)C1=CC(OC)=C(OC)C(OC)=C1 DNXIKVLOVZVMQF-UHFFFAOYSA-N 0.000 description 1
- YYGNTYWPHWGJRM-UHFFFAOYSA-N (6E,10E,14E,18E)-2,6,10,15,19,23-hexamethyltetracosa-2,6,10,14,18,22-hexaene Chemical compound CC(C)=CCCC(C)=CCCC(C)=CCCC=C(C)CCC=C(C)CCC=C(C)C YYGNTYWPHWGJRM-UHFFFAOYSA-N 0.000 description 1
- OYHQOLUKZRVURQ-NTGFUMLPSA-N (9Z,12Z)-9,10,12,13-tetratritiooctadeca-9,12-dienoic acid Chemical compound C(CCCCCCC\C(=C(/C\C(=C(/CCCCC)\[3H])\[3H])\[3H])\[3H])(=O)O OYHQOLUKZRVURQ-NTGFUMLPSA-N 0.000 description 1
- AGBQKNBQESQNJD-SSDOTTSWSA-N (R)-lipoic acid Chemical compound OC(=O)CCCC[C@@H]1CCSS1 AGBQKNBQESQNJD-SSDOTTSWSA-N 0.000 description 1
- TZCPCKNHXULUIY-RGULYWFUSA-N 1,2-distearoyl-sn-glycero-3-phosphoserine Chemical compound CCCCCCCCCCCCCCCCCC(=O)OC[C@H](COP(O)(=O)OC[C@H](N)C(O)=O)OC(=O)CCCCCCCCCCCCCCCCC TZCPCKNHXULUIY-RGULYWFUSA-N 0.000 description 1
- LDVVTQMJQSCDMK-UHFFFAOYSA-N 1,3-dihydroxypropan-2-yl formate Chemical compound OCC(CO)OC=O LDVVTQMJQSCDMK-UHFFFAOYSA-N 0.000 description 1
- PZNPLUBHRSSFHT-RRHRGVEJSA-N 1-hexadecanoyl-2-octadecanoyl-sn-glycero-3-phosphocholine Chemical compound CCCCCCCCCCCCCCCCCC(=O)O[C@@H](COP([O-])(=O)OCC[N+](C)(C)C)COC(=O)CCCCCCCCCCCCCCC PZNPLUBHRSSFHT-RRHRGVEJSA-N 0.000 description 1
- IXPNQXFRVYWDDI-UHFFFAOYSA-N 1-methyl-2,4-dioxo-1,3-diazinane-5-carboximidamide Chemical compound CN1CC(C(N)=N)C(=O)NC1=O IXPNQXFRVYWDDI-UHFFFAOYSA-N 0.000 description 1
- 229960002666 1-octacosanol Drugs 0.000 description 1
- IIZPXYDJLKNOIY-JXPKJXOSSA-N 1-palmitoyl-2-arachidonoyl-sn-glycero-3-phosphocholine Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCC\C=C/C\C=C/C\C=C/C\C=C/CCCCC IIZPXYDJLKNOIY-JXPKJXOSSA-N 0.000 description 1
- WVXRAFOPTSTNLL-NKWVEPMBSA-N 2',3'-dideoxyadenosine Chemical compound C1=NC=2C(N)=NC=NC=2N1[C@H]1CC[C@@H](CO)O1 WVXRAFOPTSTNLL-NKWVEPMBSA-N 0.000 description 1
- JXPHLUCMHXXHEJ-UHFFFAOYSA-N 2-(aminomethyl)-4-bromoaniline Chemical compound NCC1=CC(Br)=CC=C1N JXPHLUCMHXXHEJ-UHFFFAOYSA-N 0.000 description 1
- PWKSKIMOESPYIA-UHFFFAOYSA-N 2-acetamido-3-sulfanylpropanoic acid Chemical compound CC(=O)NC(CS)C(O)=O PWKSKIMOESPYIA-UHFFFAOYSA-N 0.000 description 1
- MIDXCONKKJTLDX-UHFFFAOYSA-N 3,5-dimethylcyclopentane-1,2-dione Chemical compound CC1CC(C)C(=O)C1=O MIDXCONKKJTLDX-UHFFFAOYSA-N 0.000 description 1
- NHNHLPJQBDXKSO-UHFFFAOYSA-N 4-amino-2-(pyridine-3-carbonyl)butanoic acid Chemical compound NCCC(C(O)=O)C(=O)C1=CC=CN=C1 NHNHLPJQBDXKSO-UHFFFAOYSA-N 0.000 description 1
- SQDAZGGFXASXDW-UHFFFAOYSA-N 5-bromo-2-(trifluoromethoxy)pyridine Chemical compound FC(F)(F)OC1=CC=C(Br)C=N1 SQDAZGGFXASXDW-UHFFFAOYSA-N 0.000 description 1
- 241000906543 Actaea racemosa Species 0.000 description 1
- 241000222518 Agaricus Species 0.000 description 1
- 244000251953 Agaricus brunnescens Species 0.000 description 1
- 235000001674 Agaricus brunnescens Nutrition 0.000 description 1
- JDLKFOPOAOFWQN-VIFPVBQESA-N Allicin Natural products C=CCS[S@](=O)CC=C JDLKFOPOAOFWQN-VIFPVBQESA-N 0.000 description 1
- 241000234282 Allium Species 0.000 description 1
- 235000002732 Allium cepa var. cepa Nutrition 0.000 description 1
- 240000002234 Allium sativum Species 0.000 description 1
- 229920000945 Amylopectin Polymers 0.000 description 1
- 229920000856 Amylose Polymers 0.000 description 1
- 235000007119 Ananas comosus Nutrition 0.000 description 1
- 244000099147 Ananas comosus Species 0.000 description 1
- 241000256844 Apis mellifera Species 0.000 description 1
- 235000017060 Arachis glabrata Nutrition 0.000 description 1
- 244000105624 Arachis hypogaea Species 0.000 description 1
- 235000010777 Arachis hypogaea Nutrition 0.000 description 1
- 235000018262 Arachis monticola Nutrition 0.000 description 1
- 235000016425 Arthrospira platensis Nutrition 0.000 description 1
- 240000002900 Arthrospira platensis Species 0.000 description 1
- JEBFVOLFMLUKLF-IFPLVEIFSA-N Astaxanthin Natural products CC(=C/C=C/C(=C/C=C/C1=C(C)C(=O)C(O)CC1(C)C)/C)C=CC=C(/C)C=CC=C(/C)C=CC2=C(C)C(=O)C(O)CC2(C)C JEBFVOLFMLUKLF-IFPLVEIFSA-N 0.000 description 1
- 241000186000 Bifidobacterium Species 0.000 description 1
- 235000011299 Brassica oleracea var botrytis Nutrition 0.000 description 1
- 235000017647 Brassica oleracea var italica Nutrition 0.000 description 1
- 244000308180 Brassica oleracea var. italica Species 0.000 description 1
- YDNKGFDKKRUKPY-JHOUSYSJSA-N C16 ceramide Natural products CCCCCCCCCCCCCCCC(=O)N[C@@H](CO)[C@H](O)C=CCCCCCCCCCCCCC YDNKGFDKKRUKPY-JHOUSYSJSA-N 0.000 description 1
- 241000754798 Calophyllum brasiliense Species 0.000 description 1
- BVKZGUZCCUSVTD-UHFFFAOYSA-L Carbonate Chemical compound [O-]C([O-])=O BVKZGUZCCUSVTD-UHFFFAOYSA-L 0.000 description 1
- 229920002134 Carboxymethyl cellulose Polymers 0.000 description 1
- 235000009467 Carica papaya Nutrition 0.000 description 1
- 240000006432 Carica papaya Species 0.000 description 1
- 235000003255 Carthamus tinctorius Nutrition 0.000 description 1
- 244000020518 Carthamus tinctorius Species 0.000 description 1
- 235000004032 Centella asiatica Nutrition 0.000 description 1
- 244000146462 Centella asiatica Species 0.000 description 1
- 206010065559 Cerebral arteriosclerosis Diseases 0.000 description 1
- 206010008111 Cerebral haemorrhage Diseases 0.000 description 1
- DQFBYFPFKXHELB-UHFFFAOYSA-N Chalcone Natural products C=1C=CC=CC=1C(=O)C=CC1=CC=CC=C1 DQFBYFPFKXHELB-UHFFFAOYSA-N 0.000 description 1
- GHOKWGTUZJEAQD-UHFFFAOYSA-N Chick antidermatitis factor Natural products OCC(C)(C)C(O)C(=O)NCCC(O)=O GHOKWGTUZJEAQD-UHFFFAOYSA-N 0.000 description 1
- 229920002101 Chitin Polymers 0.000 description 1
- 241000251730 Chondrichthyes Species 0.000 description 1
- 229920001287 Chondroitin sulfate Polymers 0.000 description 1
- VYZAMTAEIAYCRO-UHFFFAOYSA-N Chromium Chemical compound [Cr] VYZAMTAEIAYCRO-UHFFFAOYSA-N 0.000 description 1
- 244000223760 Cinnamomum zeylanicum Species 0.000 description 1
- 241000132536 Cirsium Species 0.000 description 1
- 241000207199 Citrus Species 0.000 description 1
- 235000008733 Citrus aurantifolia Nutrition 0.000 description 1
- 240000007154 Coffea arabica Species 0.000 description 1
- 241000190633 Cordyceps Species 0.000 description 1
- 244000301850 Cupressus sempervirens Species 0.000 description 1
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 description 1
- 229930182843 D-Lactic acid Natural products 0.000 description 1
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 description 1
- FBPFZTCFMRRESA-JGWLITMVSA-N D-glucitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-JGWLITMVSA-N 0.000 description 1
- JVTAAEKCZFNVCJ-UWTATZPHSA-N D-lactic acid Chemical compound C[C@@H](O)C(O)=O JVTAAEKCZFNVCJ-UWTATZPHSA-N 0.000 description 1
- 239000011627 DL-alpha-tocopherol Substances 0.000 description 1
- 235000001815 DL-alpha-tocopherol Nutrition 0.000 description 1
- SBJKKFFYIZUCET-JLAZNSOCSA-N Dehydro-L-ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(=O)C1=O SBJKKFFYIZUCET-JLAZNSOCSA-N 0.000 description 1
- 239000004375 Dextrin Substances 0.000 description 1
- 229920001353 Dextrin Polymers 0.000 description 1
- FEWJPZIEWOKRBE-JCYAYHJZSA-N Dextrotartaric acid Chemical compound OC(=O)[C@H](O)[C@@H](O)C(O)=O FEWJPZIEWOKRBE-JCYAYHJZSA-N 0.000 description 1
- 235000011511 Diospyros Nutrition 0.000 description 1
- 244000055850 Diospyros virginiana Species 0.000 description 1
- 239000004278 EU approved seasoning Substances 0.000 description 1
- 244000133098 Echinacea angustifolia Species 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- 241000195955 Equisetum hyemale Species 0.000 description 1
- 239000004386 Erythritol Substances 0.000 description 1
- UNXHWFMMPAWVPI-UHFFFAOYSA-N Erythritol Natural products OCC(O)C(O)CO UNXHWFMMPAWVPI-UHFFFAOYSA-N 0.000 description 1
- 240000004181 Eucalyptus cladocalyx Species 0.000 description 1
- 244000061408 Eugenia caryophyllata Species 0.000 description 1
- 229920000855 Fucoidan Polymers 0.000 description 1
- 229920000926 Galactomannan Polymers 0.000 description 1
- 235000000885 Garcinia xanthochymus Nutrition 0.000 description 1
- 244000119461 Garcinia xanthochymus Species 0.000 description 1
- 239000006000 Garlic extract Substances 0.000 description 1
- 239000009429 Ginkgo biloba extract Substances 0.000 description 1
- 102000008214 Glutamate decarboxylase Human genes 0.000 description 1
- 108091022930 Glutamate decarboxylase Proteins 0.000 description 1
- DCXXMTOCNZCJGO-UHFFFAOYSA-N Glycerol trioctadecanoate Natural products CCCCCCCCCCCCCCCCCC(=O)OCC(OC(=O)CCCCCCCCCCCCCCCCC)COC(=O)CCCCCCCCCCCCCCCCC DCXXMTOCNZCJGO-UHFFFAOYSA-N 0.000 description 1
- ZWZWYGMENQVNFU-UHFFFAOYSA-N Glycerophosphorylserin Natural products OC(=O)C(N)COP(O)(=O)OCC(O)CO ZWZWYGMENQVNFU-UHFFFAOYSA-N 0.000 description 1
- 239000004471 Glycine Substances 0.000 description 1
- 241000208251 Gymnema Species 0.000 description 1
- 206010019233 Headaches Diseases 0.000 description 1
- 229920002488 Hemicellulose Polymers 0.000 description 1
- 235000005206 Hibiscus Nutrition 0.000 description 1
- 235000007185 Hibiscus lunariifolius Nutrition 0.000 description 1
- 244000284380 Hibiscus rosa sinensis Species 0.000 description 1
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 description 1
- 235000017309 Hypericum perforatum Nutrition 0.000 description 1
- 244000141009 Hypericum perforatum Species 0.000 description 1
- 238000007696 Kjeldahl method Methods 0.000 description 1
- 239000002211 L-ascorbic acid Substances 0.000 description 1
- 235000000069 L-ascorbic acid Nutrition 0.000 description 1
- SXZYCXMUPBBULW-SKNVOMKLSA-N L-gulono-1,4-lactone Chemical compound OC[C@H](O)[C@H]1OC(=O)[C@@H](O)[C@H]1O SXZYCXMUPBBULW-SKNVOMKLSA-N 0.000 description 1
- 240000008415 Lactuca sativa Species 0.000 description 1
- 235000017858 Laurus nobilis Nutrition 0.000 description 1
- 244000165082 Lavanda vera Species 0.000 description 1
- 235000010663 Lavandula angustifolia Nutrition 0.000 description 1
- 240000000599 Lentinula edodes Species 0.000 description 1
- 235000001715 Lentinula edodes Nutrition 0.000 description 1
- 240000000759 Lepidium meyenii Species 0.000 description 1
- 235000000421 Lepidium meyenii Nutrition 0.000 description 1
- 235000004431 Linum usitatissimum Nutrition 0.000 description 1
- 240000006240 Linum usitatissimum Species 0.000 description 1
- UPYKUZBSLRQECL-UKMVMLAPSA-N Lycopene Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1C(=C)CCCC1(C)C)C=CC=C(/C)C=CC2C(=C)CCCC2(C)C UPYKUZBSLRQECL-UKMVMLAPSA-N 0.000 description 1
- JEVVKJMRZMXFBT-XWDZUXABSA-N Lycophyll Natural products OC/C(=C/CC/C(=C\C=C\C(=C/C=C/C(=C\C=C\C=C(/C=C/C=C(\C=C\C=C(/CC/C=C(/CO)\C)\C)/C)\C)/C)\C)/C)/C JEVVKJMRZMXFBT-XWDZUXABSA-N 0.000 description 1
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 1
- 240000003394 Malpighia glabra Species 0.000 description 1
- 235000014837 Malpighia glabra Nutrition 0.000 description 1
- 235000015429 Mirabilis expansa Nutrition 0.000 description 1
- 244000294411 Mirabilis expansa Species 0.000 description 1
- 235000009811 Momordica charantia Nutrition 0.000 description 1
- 244000131360 Morinda citrifolia Species 0.000 description 1
- 241000699666 Mus <mouse, genus> Species 0.000 description 1
- 235000003805 Musa ABB Group Nutrition 0.000 description 1
- 235000018290 Musa x paradisiaca Nutrition 0.000 description 1
- OVBPIULPVIDEAO-UHFFFAOYSA-N N-Pteroyl-L-glutaminsaeure Natural products C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)NC(CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-UHFFFAOYSA-N 0.000 description 1
- CRJGESKKUOMBCT-VQTJNVASSA-N N-acetylsphinganine Chemical compound CCCCCCCCCCCCCCC[C@@H](O)[C@H](CO)NC(C)=O CRJGESKKUOMBCT-VQTJNVASSA-N 0.000 description 1
- 235000015742 Nephelium litchi Nutrition 0.000 description 1
- 235000011925 Passiflora alata Nutrition 0.000 description 1
- 235000000370 Passiflora edulis Nutrition 0.000 description 1
- 235000011922 Passiflora incarnata Nutrition 0.000 description 1
- 235000013750 Passiflora mixta Nutrition 0.000 description 1
- 240000002690 Passiflora mixta Species 0.000 description 1
- 235000013731 Passiflora van volxemii Nutrition 0.000 description 1
- 102000035195 Peptidases Human genes 0.000 description 1
- 108091005804 Peptidases Proteins 0.000 description 1
- 235000004347 Perilla Nutrition 0.000 description 1
- 244000124853 Perilla frutescens Species 0.000 description 1
- 241001529469 Phoca groenlandica Species 0.000 description 1
- 235000015266 Plantago major Nutrition 0.000 description 1
- 239000002202 Polyethylene glycol Substances 0.000 description 1
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 1
- 241000241413 Propolis Species 0.000 description 1
- QOSMNYMQXIVWKY-UHFFFAOYSA-N Propyl levulinate Chemical compound CCCOC(=O)CCC(C)=O QOSMNYMQXIVWKY-UHFFFAOYSA-N 0.000 description 1
- 235000009827 Prunus armeniaca Nutrition 0.000 description 1
- 244000018633 Prunus armeniaca Species 0.000 description 1
- 244000141353 Prunus domestica Species 0.000 description 1
- 240000005809 Prunus persica Species 0.000 description 1
- 235000006040 Prunus persica var persica Nutrition 0.000 description 1
- MUPFEKGTMRGPLJ-RMMQSMQOSA-N Raffinose Natural products O(C[C@H]1[C@@H](O)[C@H](O)[C@@H](O)[C@@H](O[C@@]2(CO)[C@H](O)[C@@H](O)[C@@H](CO)O2)O1)[C@@H]1[C@H](O)[C@@H](O)[C@@H](O)[C@@H](CO)O1 MUPFEKGTMRGPLJ-RMMQSMQOSA-N 0.000 description 1
- LCQMZZCPPSWADO-UHFFFAOYSA-N Reserpilin Natural products COC(=O)C1COCC2CN3CCc4c([nH]c5cc(OC)c(OC)cc45)C3CC12 LCQMZZCPPSWADO-UHFFFAOYSA-N 0.000 description 1
- QEVHRUUCFGRFIF-SFWBKIHZSA-N Reserpine Natural products O=C(OC)[C@@H]1[C@H](OC)[C@H](OC(=O)c2cc(OC)c(OC)c(OC)c2)C[C@H]2[C@@H]1C[C@H]1N(C2)CCc2c3c([nH]c12)cc(OC)cc3 QEVHRUUCFGRFIF-SFWBKIHZSA-N 0.000 description 1
- 235000009411 Rheum rhabarbarum Nutrition 0.000 description 1
- 244000299790 Rheum rhabarbarum Species 0.000 description 1
- 235000011034 Rubus glaucus Nutrition 0.000 description 1
- 244000235659 Rubus idaeus Species 0.000 description 1
- 235000009122 Rubus idaeus Nutrition 0.000 description 1
- 241000545263 Salacia <hydroid> Species 0.000 description 1
- BUGBHKTXTAQXES-UHFFFAOYSA-N Selenium Chemical compound [Se] BUGBHKTXTAQXES-UHFFFAOYSA-N 0.000 description 1
- 240000006661 Serenoa repens Species 0.000 description 1
- 235000005318 Serenoa repens Nutrition 0.000 description 1
- 241000533293 Sesbania emerus Species 0.000 description 1
- KEAYESYHFKHZAL-UHFFFAOYSA-N Sodium Chemical compound [Na] KEAYESYHFKHZAL-UHFFFAOYSA-N 0.000 description 1
- 244000062793 Sorghum vulgare Species 0.000 description 1
- 229930182558 Sterol Natural products 0.000 description 1
- UEDUENGHJMELGK-HYDKPPNVSA-N Stevioside Chemical compound O([C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1O[C@]12C(=C)C[C@@]3(C1)CC[C@@H]1[C@@](C)(CCC[C@]1([C@@H]3CC2)C)C(=O)O[C@H]1[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O1)O)[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O UEDUENGHJMELGK-HYDKPPNVSA-N 0.000 description 1
- 235000016639 Syzygium aromaticum Nutrition 0.000 description 1
- 240000001949 Taraxacum officinale Species 0.000 description 1
- 235000005187 Taraxacum officinale ssp. officinale Nutrition 0.000 description 1
- FEWJPZIEWOKRBE-UHFFFAOYSA-N Tartaric acid Natural products [H+].[H+].[O-]C(=O)C(O)C(O)C([O-])=O FEWJPZIEWOKRBE-UHFFFAOYSA-N 0.000 description 1
- 235000005212 Terminalia tomentosa Nutrition 0.000 description 1
- 244000125380 Terminalia tomentosa Species 0.000 description 1
- BHEOSNUKNHRBNM-UHFFFAOYSA-N Tetramethylsqualene Natural products CC(=C)C(C)CCC(=C)C(C)CCC(C)=CCCC=C(C)CCC(C)C(=C)CCC(C)C(C)=C BHEOSNUKNHRBNM-UHFFFAOYSA-N 0.000 description 1
- 235000006468 Thea sinensis Nutrition 0.000 description 1
- 235000009470 Theobroma cacao Nutrition 0.000 description 1
- 235000011941 Tilia x europaea Nutrition 0.000 description 1
- 208000009205 Tinnitus Diseases 0.000 description 1
- HDTRYLNUVZCQOY-WSWWMNSNSA-N Trehalose Natural products O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@H](O)[C@@H](O)[C@@H](O)[C@@H](CO)O1 HDTRYLNUVZCQOY-WSWWMNSNSA-N 0.000 description 1
- 235000008322 Trichosanthes cucumerina Nutrition 0.000 description 1
- 244000078912 Trichosanthes cucumerina Species 0.000 description 1
- 235000021307 Triticum Nutrition 0.000 description 1
- 244000098338 Triticum aestivum Species 0.000 description 1
- MUPFEKGTMRGPLJ-UHFFFAOYSA-N UNPD196149 Natural products OC1C(O)C(CO)OC1(CO)OC1C(O)C(O)C(O)C(COC2C(C(O)C(O)C(CO)O2)O)O1 MUPFEKGTMRGPLJ-UHFFFAOYSA-N 0.000 description 1
- LEHOTFFKMJEONL-UHFFFAOYSA-N Uric Acid Chemical compound N1C(=O)NC(=O)C2=C1NC(=O)N2 LEHOTFFKMJEONL-UHFFFAOYSA-N 0.000 description 1
- TVWHNULVHGKJHS-UHFFFAOYSA-N Uric acid Natural products N1C(=O)NC(=O)C2NC(=O)NC21 TVWHNULVHGKJHS-UHFFFAOYSA-N 0.000 description 1
- 235000012545 Vaccinium macrocarpon Nutrition 0.000 description 1
- 235000017537 Vaccinium myrtillus Nutrition 0.000 description 1
- 244000078534 Vaccinium myrtillus Species 0.000 description 1
- 244000291414 Vaccinium oxycoccus Species 0.000 description 1
- 235000002118 Vaccinium oxycoccus Nutrition 0.000 description 1
- 229930003268 Vitamin C Natural products 0.000 description 1
- 229930003427 Vitamin E Natural products 0.000 description 1
- 241000269959 Xiphias gladius Species 0.000 description 1
- TVXBFESIOXBWNM-UHFFFAOYSA-N Xylitol Natural products OCCC(O)C(O)C(O)CCO TVXBFESIOXBWNM-UHFFFAOYSA-N 0.000 description 1
- JKQXZKUSFCKOGQ-LQFQNGICSA-N Z-zeaxanthin Natural products C([C@H](O)CC=1C)C(C)(C)C=1C=CC(C)=CC=CC(C)=CC=CC=C(C)C=CC=C(C)C=CC1=C(C)C[C@@H](O)CC1(C)C JKQXZKUSFCKOGQ-LQFQNGICSA-N 0.000 description 1
- 240000008042 Zea mays Species 0.000 description 1
- 235000005824 Zea mays ssp. parviglumis Nutrition 0.000 description 1
- 235000002017 Zea mays subsp mays Nutrition 0.000 description 1
- QOPRSMDTRDMBNK-RNUUUQFGSA-N Zeaxanthin Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CCC(O)C1(C)C)C=CC=C(/C)C=CC2=C(C)CC(O)CC2(C)C QOPRSMDTRDMBNK-RNUUUQFGSA-N 0.000 description 1
- 244000126002 Ziziphus vulgaris Species 0.000 description 1
- 150000007513 acids Chemical class 0.000 description 1
- 239000003463 adsorbent Substances 0.000 description 1
- 239000003513 alkali Substances 0.000 description 1
- JKQXZKUSFCKOGQ-LOFNIBRQSA-N all-trans-Zeaxanthin Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CC(O)CC1(C)C)C=CC=C(/C)C=CC2=C(C)CC(O)CC2(C)C JKQXZKUSFCKOGQ-LOFNIBRQSA-N 0.000 description 1
- 150000004347 all-trans-retinol derivatives Chemical class 0.000 description 1
- JDLKFOPOAOFWQN-UHFFFAOYSA-N allicin Chemical compound C=CCSS(=O)CC=C JDLKFOPOAOFWQN-UHFFFAOYSA-N 0.000 description 1
- 235000010081 allicin Nutrition 0.000 description 1
- HDTRYLNUVZCQOY-LIZSDCNHSA-N alpha,alpha-trehalose Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 HDTRYLNUVZCQOY-LIZSDCNHSA-N 0.000 description 1
- AGBQKNBQESQNJD-UHFFFAOYSA-N alpha-Lipoic acid Natural products OC(=O)CCCCC1CCSS1 AGBQKNBQESQNJD-UHFFFAOYSA-N 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 229960005070 ascorbic acid Drugs 0.000 description 1
- 235000013793 astaxanthin Nutrition 0.000 description 1
- 239000001168 astaxanthin Substances 0.000 description 1
- 229940022405 astaxanthin Drugs 0.000 description 1
- MQZIGYBFDRPAKN-ZWAPEEGVSA-N astaxanthin Chemical compound C([C@H](O)C(=O)C=1C)C(C)(C)C=1/C=C/C(/C)=C/C=C/C(/C)=C/C=C/C=C(C)C=CC=C(C)C=CC1=C(C)C(=O)[C@@H](O)CC1(C)C MQZIGYBFDRPAKN-ZWAPEEGVSA-N 0.000 description 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 1
- 229940069780 barley extract Drugs 0.000 description 1
- 229940069765 bean extract Drugs 0.000 description 1
- 230000003796 beauty Effects 0.000 description 1
- 239000000440 bentonite Substances 0.000 description 1
- 229910000278 bentonite Inorganic materials 0.000 description 1
- 235000012216 bentonite Nutrition 0.000 description 1
- SVPXDRXYRYOSEX-UHFFFAOYSA-N bentoquatam Chemical compound O.O=[Si]=O.O=[Al]O[Al]=O SVPXDRXYRYOSEX-UHFFFAOYSA-N 0.000 description 1
- 235000020958 biotin Nutrition 0.000 description 1
- 229960002685 biotin Drugs 0.000 description 1
- 239000011616 biotin Substances 0.000 description 1
- 230000017531 blood circulation Effects 0.000 description 1
- 229940055416 blueberry extract Drugs 0.000 description 1
- 235000019216 blueberry extract Nutrition 0.000 description 1
- 210000004958 brain cell Anatomy 0.000 description 1
- KRPUUUJWTZKSOK-YDALLXLXSA-L calcium (4S)-4-[[4-[(2-amino-4-oxidopteridin-6-yl)methylamino]benzoyl]amino]-5-hydroxy-5-oxopentanoate Chemical compound [Ca++].Nc1nc([O-])c2nc(CNc3ccc(cc3)C(=O)N[C@@H](CCC([O-])=O)C(O)=O)cnc2n1 KRPUUUJWTZKSOK-YDALLXLXSA-L 0.000 description 1
- FAPWYRCQGJNNSJ-UBKPKTQASA-L calcium D-pantothenic acid Chemical compound [Ca+2].OCC(C)(C)[C@@H](O)C(=O)NCCC([O-])=O.OCC(C)(C)[C@@H](O)C(=O)NCCC([O-])=O FAPWYRCQGJNNSJ-UBKPKTQASA-L 0.000 description 1
- AXCZMVOFGPJBDE-UHFFFAOYSA-L calcium dihydroxide Chemical compound [OH-].[OH-].[Ca+2] AXCZMVOFGPJBDE-UHFFFAOYSA-L 0.000 description 1
- 239000000920 calcium hydroxide Substances 0.000 description 1
- 229910001861 calcium hydroxide Inorganic materials 0.000 description 1
- 229960002079 calcium pantothenate Drugs 0.000 description 1
- 159000000007 calcium salts Chemical class 0.000 description 1
- CJZGTCYPCWQAJB-UHFFFAOYSA-L calcium stearate Chemical class [Ca+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O CJZGTCYPCWQAJB-UHFFFAOYSA-L 0.000 description 1
- CZHUUMMBFBPPSX-UHFFFAOYSA-L calcium;4-aminobutanoate Chemical compound [Ca+2].NCCCC([O-])=O.NCCCC([O-])=O CZHUUMMBFBPPSX-UHFFFAOYSA-L 0.000 description 1
- 229960002504 capsaicin Drugs 0.000 description 1
- 235000017663 capsaicin Nutrition 0.000 description 1
- 239000002775 capsule Substances 0.000 description 1
- 235000013736 caramel Nutrition 0.000 description 1
- 239000001569 carbon dioxide Substances 0.000 description 1
- 229910002092 carbon dioxide Inorganic materials 0.000 description 1
- 235000014171 carbonated beverage Nutrition 0.000 description 1
- 239000001768 carboxy methyl cellulose Substances 0.000 description 1
- 235000010948 carboxy methyl cellulose Nutrition 0.000 description 1
- 239000008112 carboxymethyl-cellulose Substances 0.000 description 1
- 210000000845 cartilage Anatomy 0.000 description 1
- 239000005018 casein Substances 0.000 description 1
- BECPQYXYKAMYBN-UHFFFAOYSA-N casein, tech. Chemical compound NCCCCC(C(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(CC(C)C)N=C(O)C(CCC(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(C(C)O)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(COP(O)(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(N)CC1=CC=CC=C1 BECPQYXYKAMYBN-UHFFFAOYSA-N 0.000 description 1
- 235000021240 caseins Nutrition 0.000 description 1
- 238000005119 centrifugation Methods 0.000 description 1
- 229940106189 ceramide Drugs 0.000 description 1
- ZVEQCJWYRWKARO-UHFFFAOYSA-N ceramide Natural products CCCCCCCCCCCCCCC(O)C(=O)NC(CO)C(O)C=CCCC=C(C)CCCCCCCCC ZVEQCJWYRWKARO-UHFFFAOYSA-N 0.000 description 1
- 206010008118 cerebral infarction Diseases 0.000 description 1
- 235000005513 chalcones Nutrition 0.000 description 1
- 229940112822 chewing gum Drugs 0.000 description 1
- 235000015218 chewing gum Nutrition 0.000 description 1
- 235000016019 chocolate confectionery Nutrition 0.000 description 1
- 229960001231 choline Drugs 0.000 description 1
- OEYIOHPDSNJKLS-UHFFFAOYSA-N choline Chemical compound C[N+](C)(C)CCO OEYIOHPDSNJKLS-UHFFFAOYSA-N 0.000 description 1
- 229940059329 chondroitin sulfate Drugs 0.000 description 1
- 229910052804 chromium Inorganic materials 0.000 description 1
- 239000011651 chromium Substances 0.000 description 1
- 235000005301 cimicifuga racemosa Nutrition 0.000 description 1
- 235000017803 cinnamon Nutrition 0.000 description 1
- 235000020971 citrus fruits Nutrition 0.000 description 1
- 229940110767 coenzyme Q10 Drugs 0.000 description 1
- 235000016213 coffee Nutrition 0.000 description 1
- 229920002770 condensed tannin Polymers 0.000 description 1
- 235000014510 cooky Nutrition 0.000 description 1
- 235000005822 corn Nutrition 0.000 description 1
- 235000004634 cranberry Nutrition 0.000 description 1
- 239000006071 cream Substances 0.000 description 1
- 235000013365 dairy product Nutrition 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- 239000007857 degradation product Substances 0.000 description 1
- 230000006866 deterioration Effects 0.000 description 1
- 235000019425 dextrin Nutrition 0.000 description 1
- 235000015872 dietary supplement Nutrition 0.000 description 1
- 238000007865 diluting Methods 0.000 description 1
- FPAFDBFIGPHWGO-UHFFFAOYSA-N dioxosilane;oxomagnesium;hydrate Chemical compound O.[Mg]=O.[Mg]=O.[Mg]=O.O=[Si]=O.O=[Si]=O.O=[Si]=O.O=[Si]=O FPAFDBFIGPHWGO-UHFFFAOYSA-N 0.000 description 1
- 239000007884 disintegrant Substances 0.000 description 1
- 239000002270 dispersing agent Substances 0.000 description 1
- PRAKJMSDJKAYCZ-UHFFFAOYSA-N dodecahydrosqualene Natural products CC(C)CCCC(C)CCCC(C)CCCCC(C)CCCC(C)CCCC(C)C PRAKJMSDJKAYCZ-UHFFFAOYSA-N 0.000 description 1
- 239000002552 dosage form Substances 0.000 description 1
- 235000014134 echinacea Nutrition 0.000 description 1
- 239000003623 enhancer Substances 0.000 description 1
- PEYUIKBAABKQKQ-UHFFFAOYSA-N epiasarinin Natural products C1=C2OCOC2=CC(C2OCC3C2COC3C2=CC=C3OCOC3=C2)=C1 PEYUIKBAABKQKQ-UHFFFAOYSA-N 0.000 description 1
- 229940009714 erythritol Drugs 0.000 description 1
- 235000019414 erythritol Nutrition 0.000 description 1
- UNXHWFMMPAWVPI-ZXZARUISSA-N erythritol Chemical compound OC[C@H](O)[C@H](O)CO UNXHWFMMPAWVPI-ZXZARUISSA-N 0.000 description 1
- 150000002148 esters Chemical class 0.000 description 1
- 235000019441 ethanol Nutrition 0.000 description 1
- IDGUHHHQCWSQLU-UHFFFAOYSA-N ethanol;hydrate Chemical compound O.CCO IDGUHHHQCWSQLU-UHFFFAOYSA-N 0.000 description 1
- 125000004494 ethyl ester group Chemical group 0.000 description 1
- 238000011156 evaluation Methods 0.000 description 1
- 229940045761 evening primrose extract Drugs 0.000 description 1
- 235000008524 evening primrose extract Nutrition 0.000 description 1
- 230000002964 excitative effect Effects 0.000 description 1
- 239000003925 fat Substances 0.000 description 1
- 235000019197 fats Nutrition 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- 229930003935 flavonoid Natural products 0.000 description 1
- 235000017173 flavonoids Nutrition 0.000 description 1
- 150000002215 flavonoids Chemical class 0.000 description 1
- 239000000796 flavoring agent Substances 0.000 description 1
- 235000019634 flavors Nutrition 0.000 description 1
- 235000013312 flour Nutrition 0.000 description 1
- 235000019152 folic acid Nutrition 0.000 description 1
- 239000011724 folic acid Substances 0.000 description 1
- 229960000304 folic acid Drugs 0.000 description 1
- 235000013373 food additive Nutrition 0.000 description 1
- 239000002778 food additive Substances 0.000 description 1
- 235000011389 fruit/vegetable juice Nutrition 0.000 description 1
- AQLRNQCFQNNMJA-UHFFFAOYSA-N fucoxanthin Natural products CC(=O)OC1CC(C)(C)C(=C=CC(=CC=CC(=CC=CC=C(/C)C=CC=C(/C)C(=O)CC23OC2(C)CC(O)CC3(C)C)C)CO)C(C)(O)C1 AQLRNQCFQNNMJA-UHFFFAOYSA-N 0.000 description 1
- SJWWTRQNNRNTPU-ABBNZJFMSA-N fucoxanthin Chemical compound C[C@@]1(O)C[C@@H](OC(=O)C)CC(C)(C)C1=C=C\C(C)=C\C=C\C(\C)=C\C=C\C=C(/C)\C=C\C=C(/C)C(=O)C[C@]1(C(C[C@H](O)C2)(C)C)[C@]2(C)O1 SJWWTRQNNRNTPU-ABBNZJFMSA-N 0.000 description 1
- FODTZLFLDFKIQH-FSVGXZBPSA-N gamma-Oryzanol (TN) Chemical compound C1=C(O)C(OC)=CC(\C=C\C(=O)O[C@@H]2C([C@@H]3CC[C@H]4[C@]5(C)CC[C@@H]([C@@]5(C)CC[C@@]54C[C@@]53CC2)[C@H](C)CCC=C(C)C)(C)C)=C1 FODTZLFLDFKIQH-FSVGXZBPSA-N 0.000 description 1
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 description 1
- 235000004611 garlic Nutrition 0.000 description 1
- 235000020706 garlic extract Nutrition 0.000 description 1
- 239000007789 gas Substances 0.000 description 1
- 238000007429 general method Methods 0.000 description 1
- 235000020686 ginkgo biloba extract Nutrition 0.000 description 1
- 229940068052 ginkgo biloba extract Drugs 0.000 description 1
- 235000021552 granulated sugar Nutrition 0.000 description 1
- 229940087559 grape seed Drugs 0.000 description 1
- 235000009569 green tea Nutrition 0.000 description 1
- 150000003278 haem Chemical class 0.000 description 1
- 239000007902 hard capsule Substances 0.000 description 1
- 231100000869 headache Toxicity 0.000 description 1
- 235000012907 honey Nutrition 0.000 description 1
- 229920002674 hyaluronan Polymers 0.000 description 1
- 229960003160 hyaluronic acid Drugs 0.000 description 1
- 239000008172 hydrogenated vegetable oil Substances 0.000 description 1
- 235000015243 ice cream Nutrition 0.000 description 1
- 239000003112 inhibitor Substances 0.000 description 1
- 235000021539 instant coffee Nutrition 0.000 description 1
- 201000005851 intracranial arteriosclerosis Diseases 0.000 description 1
- IQZZFVDIZRWADY-UHFFFAOYSA-N isocumarine Natural products C1=CC=C2C(=O)OC=CC2=C1 IQZZFVDIZRWADY-UHFFFAOYSA-N 0.000 description 1
- GOMNOOKGLZYEJT-UHFFFAOYSA-N isoflavone Chemical compound C=1OC2=CC=CC=C2C(=O)C=1C1=CC=CC=C1 GOMNOOKGLZYEJT-UHFFFAOYSA-N 0.000 description 1
- CJWQYWQDLBZGPD-UHFFFAOYSA-N isoflavone Natural products C1=C(OC)C(OC)=CC(OC)=C1C1=COC2=C(C=CC(C)(C)O3)C3=C(OC)C=C2C1=O CJWQYWQDLBZGPD-UHFFFAOYSA-N 0.000 description 1
- 235000008696 isoflavones Nutrition 0.000 description 1
- 235000015110 jellies Nutrition 0.000 description 1
- 239000008274 jelly Substances 0.000 description 1
- 235000021109 kimchi Nutrition 0.000 description 1
- 229960000448 lactic acid Drugs 0.000 description 1
- 239000001102 lavandula vera Substances 0.000 description 1
- 235000018219 lavender Nutrition 0.000 description 1
- 239000000787 lecithin Substances 0.000 description 1
- 235000010445 lecithin Nutrition 0.000 description 1
- 229940067606 lecithin Drugs 0.000 description 1
- 235000012902 lepidium meyenii Nutrition 0.000 description 1
- 229930013686 lignan Natural products 0.000 description 1
- 235000009408 lignans Nutrition 0.000 description 1
- 150000005692 lignans Chemical class 0.000 description 1
- 239000004571 lime Substances 0.000 description 1
- 235000019136 lipoic acid Nutrition 0.000 description 1
- 239000006210 lotion Substances 0.000 description 1
- 239000000314 lubricant Substances 0.000 description 1
- 235000012680 lutein Nutrition 0.000 description 1
- 229960005375 lutein Drugs 0.000 description 1
- 239000001656 lutein Substances 0.000 description 1
- KBPHJBAIARWVSC-RGZFRNHPSA-N lutein Chemical compound C([C@H](O)CC=1C)C(C)(C)C=1\C=C\C(\C)=C\C=C\C(\C)=C\C=C\C=C(/C)\C=C\C=C(/C)\C=C\[C@H]1C(C)=C[C@H](O)CC1(C)C KBPHJBAIARWVSC-RGZFRNHPSA-N 0.000 description 1
- ORAKUVXRZWMARG-WZLJTJAWSA-N lutein Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CCCC1(C)C)C=CC=C(/C)C=CC2C(=CC(O)CC2(C)C)C ORAKUVXRZWMARG-WZLJTJAWSA-N 0.000 description 1
- 235000012661 lycopene Nutrition 0.000 description 1
- 229960004999 lycopene Drugs 0.000 description 1
- 239000001751 lycopene Substances 0.000 description 1
- OAIJSZIZWZSQBC-GYZMGTAESA-N lycopene Chemical compound CC(C)=CCC\C(C)=C\C=C\C(\C)=C\C=C\C(\C)=C\C=C\C=C(/C)\C=C\C=C(/C)\C=C\C=C(/C)CCC=C(C)C OAIJSZIZWZSQBC-GYZMGTAESA-N 0.000 description 1
- 239000011777 magnesium Substances 0.000 description 1
- 229910052749 magnesium Inorganic materials 0.000 description 1
- 238000012423 maintenance Methods 0.000 description 1
- 239000000845 maltitol Substances 0.000 description 1
- 235000010449 maltitol Nutrition 0.000 description 1
- VQHSOMBJVWLPSR-WUJBLJFYSA-N maltitol Chemical compound OC[C@H](O)[C@@H](O)[C@@H]([C@H](O)CO)O[C@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O VQHSOMBJVWLPSR-WUJBLJFYSA-N 0.000 description 1
- 229940035436 maltitol Drugs 0.000 description 1
- 150000004667 medium chain fatty acids Chemical class 0.000 description 1
- 206010027175 memory impairment Diseases 0.000 description 1
- HEBKCHPVOIAQTA-UHFFFAOYSA-N meso ribitol Natural products OCC(O)C(O)C(O)CO HEBKCHPVOIAQTA-UHFFFAOYSA-N 0.000 description 1
- 230000007102 metabolic function Effects 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- KVQGGLZHHFGHPU-UHFFFAOYSA-N methyl 4-aminobutanoate Chemical compound COC(=O)CCCN KVQGGLZHHFGHPU-UHFFFAOYSA-N 0.000 description 1
- 235000019713 millet Nutrition 0.000 description 1
- 235000013536 miso Nutrition 0.000 description 1
- 230000008450 motivation Effects 0.000 description 1
- 210000005036 nerve Anatomy 0.000 description 1
- VVGIYYKRAMHVLU-UHFFFAOYSA-N newbouldiamide Natural products CCCCCCCCCCCCCCCCCCCC(O)C(O)C(O)C(CO)NC(=O)CCCCCCCCCCCCCCCCC VVGIYYKRAMHVLU-UHFFFAOYSA-N 0.000 description 1
- 235000005152 nicotinamide Nutrition 0.000 description 1
- 239000011570 nicotinamide Substances 0.000 description 1
- 235000017524 noni Nutrition 0.000 description 1
- 235000012149 noodles Nutrition 0.000 description 1
- 150000007523 nucleic acids Chemical class 0.000 description 1
- 102000039446 nucleic acids Human genes 0.000 description 1
- 108020004707 nucleic acids Proteins 0.000 description 1
- 235000015097 nutrients Nutrition 0.000 description 1
- 239000002674 ointment Substances 0.000 description 1
- 235000020333 oolong tea Nutrition 0.000 description 1
- 235000015205 orange juice Nutrition 0.000 description 1
- 239000001301 oxygen Substances 0.000 description 1
- 229910052760 oxygen Inorganic materials 0.000 description 1
- 238000010979 pH adjustment Methods 0.000 description 1
- 235000019161 pantothenic acid Nutrition 0.000 description 1
- 229940055726 pantothenic acid Drugs 0.000 description 1
- 239000011713 pantothenic acid Substances 0.000 description 1
- 235000020232 peanut Nutrition 0.000 description 1
- 229960000292 pectin Drugs 0.000 description 1
- 239000000546 pharmaceutical excipient Substances 0.000 description 1
- 239000000825 pharmaceutical preparation Substances 0.000 description 1
- 239000002504 physiological saline solution Substances 0.000 description 1
- 239000000049 pigment Substances 0.000 description 1
- 239000006187 pill Substances 0.000 description 1
- 235000018192 pine bark supplement Nutrition 0.000 description 1
- 210000002826 placenta Anatomy 0.000 description 1
- 238000005498 polishing Methods 0.000 description 1
- 229920001223 polyethylene glycol Polymers 0.000 description 1
- 239000001267 polyvinylpyrrolidone Substances 0.000 description 1
- 235000013855 polyvinylpyrrolidone Nutrition 0.000 description 1
- 229920000036 polyvinylpyrrolidone Polymers 0.000 description 1
- 239000011591 potassium Substances 0.000 description 1
- 229910052700 potassium Inorganic materials 0.000 description 1
- 229910000160 potassium phosphate Inorganic materials 0.000 description 1
- 235000011009 potassium phosphates Nutrition 0.000 description 1
- 235000019814 powdered cellulose Nutrition 0.000 description 1
- 229920003124 powdered cellulose Polymers 0.000 description 1
- 239000003755 preservative agent Substances 0.000 description 1
- 230000002035 prolonged effect Effects 0.000 description 1
- 230000001737 promoting effect Effects 0.000 description 1
- 229940069949 propolis Drugs 0.000 description 1
- 235000013772 propylene glycol Nutrition 0.000 description 1
- 229940106796 pycnogenol Drugs 0.000 description 1
- 125000001453 quaternary ammonium group Chemical group 0.000 description 1
- MUPFEKGTMRGPLJ-ZQSKZDJDSA-N raffinose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO[C@@H]2[C@@H]([C@@H](O)[C@@H](O)[C@@H](CO)O2)O)O1 MUPFEKGTMRGPLJ-ZQSKZDJDSA-N 0.000 description 1
- 235000020095 red wine Nutrition 0.000 description 1
- NPCOQXAVBJJZBQ-UHFFFAOYSA-N reduced coenzyme Q9 Natural products COC1=C(O)C(C)=C(CC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)C)C(O)=C1OC NPCOQXAVBJJZBQ-UHFFFAOYSA-N 0.000 description 1
- BJOIZNZVOZKDIG-MDEJGZGSSA-N reserpine Chemical compound O([C@H]1[C@@H]([C@H]([C@H]2C[C@@H]3C4=C([C]5C=CC(OC)=CC5=N4)CCN3C[C@H]2C1)C(=O)OC)OC)C(=O)C1=CC(OC)=C(OC)C(OC)=C1 BJOIZNZVOZKDIG-MDEJGZGSSA-N 0.000 description 1
- 229960003147 reserpine Drugs 0.000 description 1
- MDMGHDFNKNZPAU-UHFFFAOYSA-N roserpine Natural products C1C2CN3CCC(C4=CC=C(OC)C=C4N4)=C4C3CC2C(OC(C)=O)C(OC)C1OC(=O)C1=CC(OC)=C(OC)C(OC)=C1 MDMGHDFNKNZPAU-UHFFFAOYSA-N 0.000 description 1
- 235000012045 salad Nutrition 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- 239000010018 saw palmetto extract Substances 0.000 description 1
- DCKVNWZUADLDEH-UHFFFAOYSA-N sec-butyl acetate Chemical compound CCC(C)OC(C)=O DCKVNWZUADLDEH-UHFFFAOYSA-N 0.000 description 1
- 229910052711 selenium Inorganic materials 0.000 description 1
- 239000011669 selenium Substances 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 239000008159 sesame oil Substances 0.000 description 1
- 235000011803 sesame oil Nutrition 0.000 description 1
- VRMHCMWQHAXTOR-CMOCDZPBSA-N sesamin Natural products C1=C2OCOC2=CC([C@@H]2OC[C@@]3(C)[C@H](C=4C=C5OCOC5=CC=4)OC[C@]32C)=C1 VRMHCMWQHAXTOR-CMOCDZPBSA-N 0.000 description 1
- RMAQACBXLXPBSY-UHFFFAOYSA-N silicic acid Chemical compound O[Si](O)(O)O RMAQACBXLXPBSY-UHFFFAOYSA-N 0.000 description 1
- 235000012239 silicon dioxide Nutrition 0.000 description 1
- 235000020374 simple syrup Nutrition 0.000 description 1
- 235000020183 skimmed milk Nutrition 0.000 description 1
- 235000011888 snacks Nutrition 0.000 description 1
- 235000010413 sodium alginate Nutrition 0.000 description 1
- 239000000661 sodium alginate Substances 0.000 description 1
- 229940005550 sodium alginate Drugs 0.000 description 1
- 229910000030 sodium bicarbonate Inorganic materials 0.000 description 1
- 235000017557 sodium bicarbonate Nutrition 0.000 description 1
- 229910000029 sodium carbonate Inorganic materials 0.000 description 1
- 239000011780 sodium chloride Substances 0.000 description 1
- 239000004320 sodium erythorbate Substances 0.000 description 1
- 235000010352 sodium erythorbate Nutrition 0.000 description 1
- 239000012312 sodium hydride Substances 0.000 description 1
- 229910000104 sodium hydride Inorganic materials 0.000 description 1
- 239000001488 sodium phosphate Substances 0.000 description 1
- 229910000162 sodium phosphate Inorganic materials 0.000 description 1
- RBWSWDPRDBEWCR-RKJRWTFHSA-N sodium;(2r)-2-[(2r)-3,4-dihydroxy-5-oxo-2h-furan-2-yl]-2-hydroxyethanolate Chemical compound [Na+].[O-]C[C@@H](O)[C@H]1OC(=O)C(O)=C1O RBWSWDPRDBEWCR-RKJRWTFHSA-N 0.000 description 1
- MJGIKHNOXNRIHX-UHFFFAOYSA-M sodium;4-aminobutanoate Chemical compound [Na+].NCCCC([O-])=O MJGIKHNOXNRIHX-UHFFFAOYSA-M 0.000 description 1
- 235000014214 soft drink Nutrition 0.000 description 1
- 239000000600 sorbitol Substances 0.000 description 1
- 235000010356 sorbitol Nutrition 0.000 description 1
- 235000014347 soups Nutrition 0.000 description 1
- 235000020712 soy bean extract Nutrition 0.000 description 1
- 235000013555 soy sauce Nutrition 0.000 description 1
- 235000012424 soybean oil Nutrition 0.000 description 1
- 239000003549 soybean oil Substances 0.000 description 1
- 239000008347 soybean phospholipid Substances 0.000 description 1
- 229940082787 spirulina Drugs 0.000 description 1
- 235000011496 sports drink Nutrition 0.000 description 1
- 238000001694 spray drying Methods 0.000 description 1
- 229940031439 squalene Drugs 0.000 description 1
- TUHBEKDERLKLEC-UHFFFAOYSA-N squalene Natural products CC(=CCCC(=CCCC(=CCCC=C(/C)CCC=C(/C)CC=C(C)C)C)C)C TUHBEKDERLKLEC-UHFFFAOYSA-N 0.000 description 1
- 239000003381 stabilizer Substances 0.000 description 1
- 230000001954 sterilising effect Effects 0.000 description 1
- 238000004659 sterilization and disinfection Methods 0.000 description 1
- 150000003432 sterols Chemical class 0.000 description 1
- 235000003702 sterols Nutrition 0.000 description 1
- OHHNJQXIOPOJSC-UHFFFAOYSA-N stevioside Natural products CC1(CCCC2(C)C3(C)CCC4(CC3(CCC12C)CC4=C)OC5OC(CO)C(O)C(O)C5OC6OC(CO)C(O)C(O)C6O)C(=O)OC7OC(CO)C(O)C(O)C7O OHHNJQXIOPOJSC-UHFFFAOYSA-N 0.000 description 1
- 229940013618 stevioside Drugs 0.000 description 1
- 235000019202 steviosides Nutrition 0.000 description 1
- 239000001384 succinic acid Substances 0.000 description 1
- 235000011044 succinic acid Nutrition 0.000 description 1
- 238000000194 supercritical-fluid extraction Methods 0.000 description 1
- 239000006228 supernatant Substances 0.000 description 1
- 239000000725 suspension Substances 0.000 description 1
- 235000021335 sword fish Nutrition 0.000 description 1
- 239000006188 syrup Substances 0.000 description 1
- 235000020357 syrup Nutrition 0.000 description 1
- 239000000454 talc Substances 0.000 description 1
- 229910052623 talc Inorganic materials 0.000 description 1
- 235000012222 talc Nutrition 0.000 description 1
- 239000001648 tannin Substances 0.000 description 1
- 235000018553 tannin Nutrition 0.000 description 1
- 229920001864 tannin Polymers 0.000 description 1
- 239000011975 tartaric acid Substances 0.000 description 1
- 235000002906 tartaric acid Nutrition 0.000 description 1
- 229960003080 taurine Drugs 0.000 description 1
- 150000003505 terpenes Chemical class 0.000 description 1
- 125000000999 tert-butyl group Chemical group [H]C([H])([H])C(*)(C([H])([H])[H])C([H])([H])[H] 0.000 description 1
- 238000010998 test method Methods 0.000 description 1
- 229960002663 thioctic acid Drugs 0.000 description 1
- 229940098465 tincture Drugs 0.000 description 1
- 231100000886 tinnitus Toxicity 0.000 description 1
- 229960000984 tocofersolan Drugs 0.000 description 1
- 235000010384 tocopherol Nutrition 0.000 description 1
- 229930003799 tocopherol Natural products 0.000 description 1
- 239000011732 tocopherol Substances 0.000 description 1
- 229960001295 tocopherol Drugs 0.000 description 1
- DQFBYFPFKXHELB-VAWYXSNFSA-N trans-chalcone Chemical compound C=1C=CC=CC=1C(=O)\C=C\C1=CC=CC=C1 DQFBYFPFKXHELB-VAWYXSNFSA-N 0.000 description 1
- ZCIHMQAPACOQHT-ZGMPDRQDSA-N trans-isorenieratene Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/c1c(C)ccc(C)c1C)C=CC=C(/C)C=Cc2c(C)ccc(C)c2C ZCIHMQAPACOQHT-ZGMPDRQDSA-N 0.000 description 1
- 150000003625 trehaloses Chemical class 0.000 description 1
- UFTFJSFQGQCHQW-UHFFFAOYSA-N triformin Chemical compound O=COCC(OC=O)COC=O UFTFJSFQGQCHQW-UHFFFAOYSA-N 0.000 description 1
- RYFMWSXOAZQYPI-UHFFFAOYSA-K trisodium phosphate Chemical compound [Na+].[Na+].[Na+].[O-]P([O-])([O-])=O RYFMWSXOAZQYPI-UHFFFAOYSA-K 0.000 description 1
- 229940035936 ubiquinone Drugs 0.000 description 1
- 235000019583 umami taste Nutrition 0.000 description 1
- 235000019607 umami taste sensations Nutrition 0.000 description 1
- 229940116269 uric acid Drugs 0.000 description 1
- 230000001457 vasomotor Effects 0.000 description 1
- 239000000052 vinegar Substances 0.000 description 1
- 235000021419 vinegar Nutrition 0.000 description 1
- 235000019154 vitamin C Nutrition 0.000 description 1
- 239000011718 vitamin C Substances 0.000 description 1
- 235000019165 vitamin E Nutrition 0.000 description 1
- 239000011709 vitamin E Substances 0.000 description 1
- 229940046009 vitamin E Drugs 0.000 description 1
- 238000003809 water extraction Methods 0.000 description 1
- 239000010497 wheat germ oil Substances 0.000 description 1
- FJHBOVDFOQMZRV-XQIHNALSSA-N xanthophyll Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CC(O)CC1(C)C)C=CC=C(/C)C=CC2C=C(C)C(O)CC2(C)C FJHBOVDFOQMZRV-XQIHNALSSA-N 0.000 description 1
- 239000000811 xylitol Substances 0.000 description 1
- 235000010447 xylitol Nutrition 0.000 description 1
- HEBKCHPVOIAQTA-SCDXWVJYSA-N xylitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)CO HEBKCHPVOIAQTA-SCDXWVJYSA-N 0.000 description 1
- 229960002675 xylitol Drugs 0.000 description 1
- 235000010930 zeaxanthin Nutrition 0.000 description 1
- 239000001775 zeaxanthin Substances 0.000 description 1
- 229940043269 zeaxanthin Drugs 0.000 description 1
Images
Landscapes
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Plant Substances (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
Description
本発明は、天然由来の成分を有効成分とする抗疲労用組成物に関するものである。 The present invention relates to an anti-fatigue composition comprising a naturally-derived component as an active ingredient.
γ−アミノ酪酸は、動植物界に広く分布しているアミノ酸の一種であり、動物の脳髓に存在し神経の主要な抑制性伝達物質として、脳の血流を活発にし、脳への酸素供給量を増加させ、脳細胞の代謝機能を促進させるものとして知られている。また、脳卒中後遺症、脳動脈硬化症などによる頭痛、耳鳴り、記憶障害、意欲低下などの症状を改善する作用、延髓の血管運動中枢に作用して、血圧を降下させる作用などが認められている。
医薬品として販売されているγ−アミノ酪酸製剤(合成品)には、脳代謝促進作用があり、脳梗塞・脳出血後遺症等、脳血管障害の諸症状の改善や血圧上昇抑制効果が認められている。
そこで、生理活性機能として血圧上昇抑制効果等の効能を有するものとして、γ−アミノ酪酸を富化した食品素材を含むものが知られている。尚、γ−アミノ酪酸を富化した食品素材に関連する技術として、以下の特許文献1及び特許文献2が知られている。
γ-Aminobutyric acid is a type of amino acid widely distributed in the animal and plant kingdoms. It is present in the brain folds of animals and is the main inhibitory transmitter of nerves. It activates blood flow in the brain and supplies oxygen to the brain. It is known to increase the amount and promote the metabolic function of brain cells. In addition, it has been recognized to have an effect of improving symptoms such as headache, tinnitus, memory impairment, decreased motivation due to stroke sequelae, cerebral arteriosclerosis, etc., and an effect of lowering blood pressure by acting on the vasomotor center of extension.
Γ-Aminobutyric acid preparations (synthetic products) sold as pharmaceuticals have a brain metabolism promoting effect, and have been found to improve various symptoms of cerebrovascular disorders such as cerebral infarction and cerebral hemorrhage sequelae, and to suppress blood pressure increase. .
Then, what contains the foodstuff material which enriched (gamma) -aminobutyric acid is known as what has effects, such as a blood-pressure rise inhibitory effect, as a physiologically active function. In addition, the following
このような背景の下、本発明者は、米由来のγ−アミノ酪酸類を含有する米抽出物に精神的疲労や肉体的疲労、特に精神的疲労を軽減する作用を有することを見出し、本発明を完成した。また、γ−アミノ酪酸類とその他の米由来の成分(ペプチド類、脂質、糖類等)との両方を含有することにより、精神的疲労を更に軽減させることを見出し、本発明を完成させた。更に、米抽出物は、天然の食用植物に由来する組成物であって、副作用がなく長期にわたって摂取できるものである。
そこで、本発明の目的は、疲労、特に精神的な疲労を軽減する機能を有し、且つ、安全な食品組成物又は医薬組成物又は化粧品用組成物を提供することである。
Under such a background, the present inventor has found that rice extract containing γ-aminobutyric acid derived from rice has an action of reducing mental fatigue and physical fatigue, particularly mental fatigue. Completed the invention. Moreover, it discovered that mental fatigue was further reduced by containing both (gamma) -aminobutyric acids and other rice-derived components (peptides, lipids, saccharides, etc.), and completed the present invention. Furthermore, the rice extract is a composition derived from a natural edible plant and has no side effects and can be ingested over a long period of time.
Accordingly, an object of the present invention is to provide a safe food composition, pharmaceutical composition or cosmetic composition having a function of reducing fatigue, particularly mental fatigue.
上記課題を解決するために、本発明の抗疲労用組成物は、米胚芽、胚芽を含む米糠、胚芽米、玄米、発芽玄米、白米のうちの少なくとも1種から抽出された米抽出物(A)を有効成分とし、該米抽出物(A)には、米由来のγ−アミノ酪酸類(a−1)を含有することを特徴とする。
また、前記米由来のγ−アミノ酪酸類(a−1)の含有量は、前記米抽出物を100質量%とした場合、γ−アミノ酪酸換算で1〜99質量%であることが好ましい。
更に、前記米抽出物(A)は、米由来のペプチド類(a−2)を含有することが好ましい。
また、前記ペプチドの含有量類(a−2)は、該米抽出物の含有量を100質量%とした場合、たんぱく質換算で0.1〜35質量%であることが好ましい。
更に、前記米抽出物(A)は、米由来の糖類(a−3)を含有することが好ましい。
また、前記米抽出物(A)は、米由来の脂質(a−4)を含有することが好ましい。
更に、前記米抽出物(A)は、米由来の食物繊維(a−5)を含有することが好ましい。
また、前記抗疲労用組成物は、γ−アミノ酪酸(B)を更に含有することが好ましい。
In order to solve the above problems, the anti-fatigue composition of the present invention is a rice extract extracted from at least one of rice germ, rice bran containing germ, germ rice, brown rice, germinated brown rice, and white rice (A ) As an active ingredient, and the rice extract (A) contains γ-aminobutyric acid (a-1) derived from rice.
The content of the rice-derived γ-aminobutyric acid (a-1) is preferably 1 to 99% by mass in terms of γ-aminobutyric acid when the rice extract is 100% by mass.
Furthermore, the rice extract (A) preferably contains rice-derived peptides (a-2).
The peptide content (a-2) is preferably 0.1 to 35% by mass in terms of protein when the content of the rice extract is 100% by mass.
Furthermore, it is preferable that the said rice extract (A) contains the saccharide | sugar (a-3) derived from rice.
Moreover, it is preferable that the said rice extract (A) contains the lipid (a-4) derived from rice.
Furthermore, it is preferable that the said rice extract (A) contains the dietary fiber (a-5) derived from rice.
The anti-fatigue composition preferably further contains γ-aminobutyric acid (B).
以下、本発明を詳細に説明する。
本発明の抗疲労用組成物は、米胚芽、胚芽を含む米糠、胚芽米のうちの少なくとも1種から抽出された米抽出物(A)を有効成分とするものである。
また、上記米抽出物(A)には、米由来のγ−アミノ酪酸類(a−1)を含有することを特徴とするものである。
上記「米由来のγ−アミノ酪酸類(a−1)」とは、米胚芽、胚芽を含む米糠、胚芽米、玄米、発芽玄米、白米のうちの少なくとも1種(以下、単に、「米胚芽等」ともいう。)から抽出され、米胚芽等に含有される成分(例えばグルタミン酸等)が変化することによって生成されたγ−アミノ酪酸(以下、GABAということがある。)及びその誘導体のことをいう。ここで、本発明におけるGABAの誘導体とは、塩類、エステル類等とが挙げられ、より詳細には、ニコチノイルγ−アミノ酪酸、γ−アミノ酪酸カルシウム塩、γ−アミノ酪酸ナトリウム塩、γ−アミノ酪酸マグネシウム塩、GABAのメチルエステル、エチルエステル、プロピルエステル、イソプロピルエステル、ブチルエステル、tert−ブチルエステル等が挙げられる。尚、これらは、1種のみを含有していても良いし、2種類以上含有していても良い。
Hereinafter, the present invention will be described in detail.
The anti-fatigue composition of the present invention comprises, as an active ingredient, rice extract (A) extracted from at least one of rice germ, rice bran containing germ, and germ rice.
The rice extract (A) contains γ-aminobutyric acid (a-1) derived from rice.
The above-mentioned “rice-derived γ-aminobutyric acid (a-1)” means at least one of rice germ, rice bran containing germ, germ rice, brown rice, germinated brown rice, and white rice (hereinafter simply referred to as “rice germ” Γ-aminobutyric acid (hereinafter sometimes referred to as GABA) and its derivatives, which are produced by changing components (eg, glutamic acid, etc.) extracted from rice germ and the like. Say. Here, the derivatives of GABA in the present invention include salts, esters and the like, and more specifically, nicotinoyl γ-aminobutyric acid, γ-aminobutyric acid calcium salt, γ-aminobutyric acid sodium salt, γ-amino Examples include magnesium butyrate, GABA methyl ester, ethyl ester, propyl ester, isopropyl ester, butyl ester, and tert-butyl ester. In addition, these may contain only 1 type and may contain 2 or more types.
また、上記γ−アミノ酪酸類(a−1)の含有量は特に限定されないが、前記米抽出物(A)を100質量%とした場合、γ−アミノ酪酸換算(換算係数7.36)にて、1〜99質量%、好ましくは3〜55質量%、より好ましくは4〜30質量%、更に好ましくは4〜10質量%であることが好ましい。1質量%未満の場合、或いは99質量%を超えた場合、疲労を軽減する機能が弱まるからである。尚、上記γ−アミノ酪酸類(a−1)の含有量は、財団法人日本食品分析センターのアミノ酸自動分析法、或いは、HPLCにて測定することができ、これらの2つの測定方法のうち少なくとも一方が上記含有量の範囲に入っていれば良い。また、HPLCにて測定する場合、γ−アミノ酪酸の測定条件は、γ−アミノ酪酸を測定するための一般的な方法を用いればよく、これらのうちの少なくともひとつの測定条件で測定した場合に上記範囲に入っていれば良い。尚、このときに用いる窒素−γ−アミノ酪酸係数は、7.36とする。 In addition, the content of the γ-aminobutyric acid (a-1) is not particularly limited, but when the rice extract (A) is 100% by mass, in terms of γ-aminobutyric acid (a conversion factor of 7.36). 1 to 99% by mass, preferably 3 to 55% by mass, more preferably 4 to 30% by mass, and still more preferably 4 to 10% by mass. This is because if it is less than 1% by mass or exceeds 99% by mass, the function of reducing fatigue is weakened. In addition, content of the said (gamma) -aminobutyric acid (a-1) can be measured by the amino acid automatic analysis method of Japan Food Research Center, or HPLC, At least among these two measuring methods One should just be in the said range of content. Moreover, when measuring by HPLC, the measurement conditions of (gamma) -aminobutyric acid should just use the general method for measuring (gamma) -aminobutyric acid, and when measuring at least one of these measurement conditions, It only has to be within the above range. The nitrogen-γ-aminobutyric acid coefficient used at this time is 7.36.
上記「米由来のペプチド類(a−2)」とは、米胚芽等から抽出され、又は米胚芽等に含有される成分が変化することによって生成されたアミノ酸、及びその誘導体、並びにアミノ酸、及びその誘導体がペプチド結合したものであって、且つ、上記γ−アミノ酪酸類(a−1)を除くものをいう。 The above “rice-derived peptides (a-2)” is an amino acid extracted from rice germ or the like, or produced by changing components contained in rice germ or the like, and derivatives thereof, and amino acids, and The derivative is a peptide-bonded one and excludes the γ-aminobutyric acid (a-1).
米由来のペプチド類(a−2)の含有量は特に限定されないが、前記米抽出物(A)を100質量%とした場合、たんぱく質換算にて、0.01〜35質量%、好ましくは、0.1〜20質量%、より好ましくは1〜15質量%、更に好ましくは3〜10質量%とすることができる。このとき、米由来のペプチド類(a−2)の含有量Z(質量%)は前記米抽出物(A)を100質量%とした場合における窒素成分の含有量をケルダール法にて定量し、その窒素の含有量をX、上記γ−アミノ酪酸類(a−1)の含有量をYとした場合、以下の式にて求めることができる。 The content of the rice-derived peptides (a-2) is not particularly limited, but when the rice extract (A) is 100% by mass, 0.01 to 35% by mass, preferably in terms of protein, It can be 0.1-20 mass%, More preferably, it is 1-15 mass%, More preferably, it can be 3-10 mass%. At this time, the content Z (mass%) of the rice-derived peptides (a-2) is quantified by the Kjeldahl method when the rice extract (A) is 100 mass%, When the content of nitrogen is X and the content of the γ-aminobutyric acid (a-1) is Y, it can be obtained by the following formula.
Z=〔X−(Y/7.36)〕×6.25
式(1)
Z = [X− (Y / 7.36)] × 6.25
Formula (1)
尚、上記式(1)の7.36は、γ−アミノ酪酸の分子量(103.12)を窒素の原子量(14.0067)で割った数値(即ち、窒素−GABA換算係数)であり、6.25は、窒素−たんぱく質換算係数である。
即ち、米由来のペプチド(a−2)類の含有量(Z)は、全窒素成分の含有量Xから、上記γ−アミノ酪酸類(a−1)の含有量Yを窒素換算に変換したものを減じ、その後、窒素−たんぱく質換算係数である6.25を掛けることによって算出することができる。
Note that 7.36 in the above formula (1) is a numerical value obtained by dividing the molecular weight of γ-aminobutyric acid (103.12) by the atomic weight of nitrogen (14.0067) (ie, nitrogen-GABA conversion factor). .25 is a nitrogen-protein conversion factor.
That is, the content (Z) of the peptide (a-2) derived from rice was converted from the content X of the total nitrogen component to the content Y of the γ-aminobutyric acid (a-1) in terms of nitrogen. It can be calculated by subtracting one and then multiplying by 6.25 which is a nitrogen-protein conversion factor.
また、上記米抽出物(A)は、米由来の糖類(a−3)を含有しても良い。上記「米由来の糖類(a−3)」は、米胚芽等から抽出されたものであれば特に限定されず、例えば、アミロース、アミロペクチン、ラフィノース、エリスリトール、グルコース、ショ糖、果糖、キシリトール、ラクトース、マルトース、マルチトール、トレハロース、アルキル化トレハロース等が挙げられるが、これらに限定されない。 Moreover, the said rice extract (A) may contain the saccharide | sugar (a-3) derived from rice. The “rice-derived saccharide (a-3)” is not particularly limited as long as it is extracted from rice germ or the like. For example, amylose, amylopectin, raffinose, erythritol, glucose, sucrose, fructose, xylitol, lactose , Maltose, maltitol, trehalose, alkylated trehalose, and the like.
上記米由来の糖類(a−3)の含有量は特に限定されないが、上記米抽出物(A)の含有量を100質量%とした場合、10〜70質量%、好ましくは13〜60質量%、より好ましくは15〜58質量%であることが好ましい。 Although content of the said rice-derived saccharide | sugar (a-3) is not specifically limited, When content of the said rice extract (A) is 100 mass%, it is 10-70 mass%, Preferably it is 13-60 mass%. More preferably, the content is 15 to 58% by mass.
更に、上記米抽出物(A)は、米由来の脂質(a−4)を含有しても良い。上記「米由来の脂質(a−4)」としては、米胚芽等から抽出され、又は米胚芽等に含有される成分が変化することによって生成されたものであれば特に限定されず、例えば、モノグリセリド、ジグリセリド、トリグリセリド、γ−オリザノール、トコフェロール、トコトリエノール、オクタサノール、ステロール、テルペノイド、スフィンゴ糖脂質、及びスフィンゴリン脂質等が挙げられるが、これらに限定されない。 Further, the rice extract (A) may contain rice-derived lipid (a-4). The “rice-derived lipid (a-4)” is not particularly limited as long as it is extracted from rice germ or the like, or produced by changing components contained in rice germ or the like. Examples thereof include, but are not limited to, monoglyceride, diglyceride, triglyceride, γ-oryzanol, tocopherol, tocotrienol, octasanol, sterol, terpenoid, sphingoglycolipid, and sphingophospholipid.
上記米由来の脂質(a−4)の含有量は特に限定されないが、上記米抽出物(A)の含有量を100質量%とした場合、0.01〜1質量%、好ましくは0.1〜0.8質量%、より好ましくは0.2〜0.7質量%とすることができる。 Although content of the said rice origin lipid (a-4) is not specifically limited, When content of the said rice extract (A) is 100 mass%, 0.01-1 mass%, Preferably it is 0.1. -0.8 mass%, More preferably, it can be 0.2-0.7 mass%.
また、上記米抽出物(A)は、米由来の食物繊維(a−5)を含有していても良い。上記「米由来の食物繊維(a−5)」としては、米胚芽等から抽出され、又は米胚芽等に含有される成分が変化することによって生成されたものであれば特に限定されず、例えば、不溶性食物繊維または水溶性食物繊維のいずれもが含まれ、例えば、セルロース、ヘミセルロース、キトサン、ガラクトマンナン、ペクチン、サイリウム、カラーギナンおよびこれらの誘導体等が挙げられるが、これらに限定されない。
上記米由来の食物繊維(a−5)の含有量は特に限定されないが、上記米抽出物(A)の含有量を100質量%とした場合、0.1〜5質量%、好ましくは0.2〜4質量%とすることができる。
Moreover, the said rice extract (A) may contain the dietary fiber (a-5) derived from rice. The “rice-derived dietary fiber (a-5)” is not particularly limited as long as it is extracted from rice germ or the like, or is produced by changing the components contained in rice germ or the like. Insoluble dietary fiber or water-soluble dietary fiber is included, and examples thereof include, but are not limited to, cellulose, hemicellulose, chitosan, galactomannan, pectin, psyllium, carrageenan, and derivatives thereof.
The content of the rice-derived dietary fiber (a-5) is not particularly limited. When the content of the rice extract (A) is 100% by mass, the content is 0.1 to 5% by mass, preferably 0.8. It can be 2-4 mass%.
上記米抽出物(A)の製造方法は特に限定されないが、例えば、米胚芽等をpH2.5〜7.5かつ50℃以下の条件で水に浸漬し、その後、酸にて抽出し、抽出物をイオン交換クロマトグラフィーにより精製することにより、製造することができる。 Although the manufacturing method of the said rice extract (A) is not specifically limited, For example, rice germ etc. are immersed in water on the conditions of pH 2.5-7.5 and 50 degrees C or less, Then, it extracts with an acid, extraction It can be produced by purifying the product by ion exchange chromatography.
上記米抽出物(A)の製造に用いる米は品種を限定しないが、胚芽重量割合の高いもの、例えば巨大胚米並びにγ−アミノ酪酸生成量の大きな品種(例えば北海269号等の米等)の利用がより好ましい。胚芽米は、米を通常の精米機(例えば柳沢製作所製、RMA−150等)で精米し、糠を除去することにより容易に調製することができる。胚芽は、胚芽米をさらに研削式精米機(例えば佐竹製作所製、TM5等)で研削した後、適当なふるい(32メッシュ程度)で胚乳部由来の粉及び糠から分け取ることができる。
更に、上記米胚芽等は、脱脂を行ったものを用いることが好ましい。γ−アミノ酪酸の劣化の原因となる遊離脂肪酸を除去することができるからである。
この脱脂の方法は特に限定されえないが、油溶性溶媒(脱脂用溶媒)にて、油分を抽出分離することにより行うことができる。また、更にこのときに用いられる脱脂用溶媒は、油溶性のものであれば特に限定されず、例えば、アセトン及びn−ヘキサン等が挙げられるが、特にn−ヘキサンが好ましい。遊離脂肪酸が効率よく除去することができ、また、抽出油分を食用油として使用し得るとともに、上記米抽出物を食品素材等に利用しやすくなるからである。
また、超臨界抽出により、脱脂を行うこともできる。このとき、炭酸ガスを用いることが最も好ましい。
The rice used for the production of the rice extract (A) is not limited to varieties, but those having a high embryo weight ratio, for example, giant embryo rice and varieties having a large amount of γ-aminobutyric acid (eg, rice from North Sea No. 269, etc.) Is more preferable. The germinated rice can be easily prepared by polishing the rice with an ordinary rice mill (for example, RMA-150 manufactured by Yanagisawa Seisakusho) and removing the koji. The embryo can be separated from the endosperm portion-derived flour and koji using a suitable sieve (about 32 mesh) after the germinated rice is further ground by a grinding-type rice mill (eg, manufactured by Satake Seisakusho, TM5).
Further, it is preferable to use a degreased rice germ. This is because free fatty acids that cause deterioration of γ-aminobutyric acid can be removed.
The degreasing method is not particularly limited, but it can be carried out by extracting and separating oil with an oil-soluble solvent (degreasing solvent). Further, the degreasing solvent used at this time is not particularly limited as long as it is oil-soluble, and examples thereof include acetone and n-hexane, and n-hexane is particularly preferable. This is because free fatty acids can be efficiently removed, the extracted oil can be used as an edible oil, and the rice extract can be easily used as a food material.
Moreover, degreasing can also be performed by supercritical extraction. At this time, it is most preferable to use carbon dioxide gas.
上記米抽出物(A)の製造は、米胚芽等に、所定のpHにて調製された水を加えることにより行うことができる。この処理によって、胚芽に内在するグルタミン酸脱炭酸酵素を作用させ、グルタミン酸をγ−アミノ酪酸に変換することができる。この時、蛋白質分解酵素も同時に作用し、米胚芽等に含まれる蛋白質が分解し、グルタミン酸が供給され、効率よくγ−アミノ酪酸に変換することができる。
このとき、水のpHは、pH2.5〜7.5、好ましくはpH3.0〜7.0、より好ましくはpH5.5〜6.0であることが好ましい。なお、pH調整のために用いる酸は有機酸,無機酸のいずれでもよく、好ましくは酢酸,クエン酸,リンゴ酸等の有機酸や塩酸,硫酸,リン酸等の無機酸が用いられる。また、アルカリとしては水酸化ナトリウム,水酸化カリウム,水酸化カルシウム,炭酸ナトリウム,リン酸ナトリウム等が用いられる。更に、このときに加える水の量は特に限定されないが、米胚芽等の2〜10倍量の水を加えることが好ましい。またこのときの水の温度、振盪の条件は、50℃以下、通常は10〜50℃の条件下、50〜150ストローク/分で20分以上、通常20分〜24時間、好ましくは80〜120ストローク/分で40分〜10時間、より好ましくは40℃で100ストローク/分にて、4〜8時間振盪させることが好ましい。
The rice extract (A) can be produced by adding water prepared at a predetermined pH to rice germ or the like. By this treatment, glutamic acid decarboxylase present in the germ can act to convert glutamic acid into γ-aminobutyric acid. At this time, the proteolytic enzyme also acts simultaneously, the protein contained in rice germ and the like is decomposed, glutamic acid is supplied, and it can be efficiently converted to γ-aminobutyric acid.
At this time, the pH of water is preferably pH 2.5 to 7.5, preferably pH 3.0 to 7.0, and more preferably pH 5.5 to 6.0. The acid used for pH adjustment may be either an organic acid or an inorganic acid, preferably an organic acid such as acetic acid, citric acid or malic acid, or an inorganic acid such as hydrochloric acid, sulfuric acid or phosphoric acid. As the alkali, sodium hydroxide, potassium hydroxide, calcium hydroxide, sodium carbonate, sodium phosphate or the like is used. Furthermore, the amount of water added at this time is not particularly limited, but it is preferable to add 2 to 10 times the amount of water such as rice germ. The temperature of the water and shaking conditions at this time are 50 ° C. or lower, usually 10 to 50 ° C., 50 to 150 strokes / minute for 20 minutes or longer, usually 20 minutes to 24 hours, preferably 80 to 120. It is preferable to shake at a stroke / minute for 40 minutes to 10 hours, more preferably at 40 ° C. at 100 strokes / minute for 4 to 8 hours.
また、上記米抽出物(A)は、上記のように浸漬処理して得た浸漬物に酸を加えて抽出することによって得ることができる。具体的には塩酸,硫酸,リン酸等の無機酸や酢酸,クエン酸,リンゴ酸等の有機酸を加えて酸性条件、好ましくはpH1〜2の強酸性条件に調整した後、0〜70℃、好ましくは10〜30℃、50〜150ストローク/分で5分〜2時間、好ましくは100ストローク/分で1時間振盪させ、γ−アミノ酪酸を抽出する。次いで、抽出物を遠心分離(3000rpm,10分),濾過処理等の固−液分離操作を行って上清(抽出液)を回収する。 Moreover, the said rice extract (A) can be obtained by adding and extracting an acid to the immersion material obtained by immersion treatment as mentioned above. Specifically, an inorganic acid such as hydrochloric acid, sulfuric acid or phosphoric acid or an organic acid such as acetic acid, citric acid or malic acid is added to adjust to acidic conditions, preferably strongly acidic conditions of pH 1-2, and then 0 to 70 ° C. The mixture is shaken at 10 to 30 ° C., 50 to 150 strokes / minute for 5 minutes to 2 hours, and preferably 100 strokes / minute for 1 hour to extract γ-aminobutyric acid. Next, the extract is subjected to solid-liquid separation operations such as centrifugation (3000 rpm, 10 minutes) and filtration, and the supernatant (extract) is recovered.
次いで、この抽出液をイオン交換クロマトグラフィー等により精製、濃縮する。
得られたγ−アミノ酪酸は甘味を伴ったうま味を有しており、食品添加物あるいは調味料として利用することができる。その場合の使用量は、目的に応じて適宜決定すればよい。
Subsequently, this extract is purified and concentrated by ion exchange chromatography or the like.
The obtained γ-aminobutyric acid has a sweet umami taste and can be used as a food additive or seasoning. The amount used in that case may be appropriately determined according to the purpose.
また、本発明の抗疲労用組成物は、γ−アミノ酪酸(B)を更に含有しても良い。ここで、上記「γ−アミノ酪酸(B)」とは、上記米由来のγ−アミノ酪酸類(a−1)とは、異なる方法にて得られたγ−アミノ酪酸であり、例えば、合成によって得られたものや、上記米抽出物(A)、米胚芽等、小麦、及びキムチ等を含むものを培地として用いて発酵させることによって得られたもの等が挙げられる。 The anti-fatigue composition of the present invention may further contain γ-aminobutyric acid (B). Here, the “γ-aminobutyric acid (B)” is γ-aminobutyric acid obtained by a method different from the rice-derived γ-aminobutyric acid (a-1). And the one obtained by fermenting the rice extract (A), rice germ, etc., containing wheat, kimchi and the like as a medium.
本発明の抗疲労用組成物は、各種飲食品の素材として使用することができる。飲食品としては、例えば、食用油(サラダ油)、菓子類(ガム、キャンディー、キャラメル、チョコレート、クッキー、スナック、ゼリー、グミ、錠菓等)、麺類(そば、うどん、ラーメン等)、乳製品(ミルク、アイスクリーム、ヨーグルト等)、調味料(味噌、醤油等)、スープ類、飲料(ジュース、コーヒー、紅茶、茶、炭酸飲料、スポーツ飲料等)をはじめとする一般食品や、健康食品(錠剤、カプセル等)、栄養補助食品(栄養ドリンク等)が挙げられる。これらの飲食品に本発明の抗疲労用組成物を適宜配合するとよい。
これら飲食品には、その種類に応じて種々の成分を配合することができ、例えば、ブドウ糖、果糖、ショ糖、マルトース、ソルビトール、ステビオサイド、コーンシロップ、乳糖、クエン酸、酒石酸、リンゴ酸、コハク酸、乳酸、L−アスコルビン酸、dl−α−トコフェロール、エリソルビン酸ナトリウム、グリセリン、プロピレングリコール、グリセリン脂肪酸エステル、ポリグリセリン脂肪酸エステル、ショ糖脂肪酸エステル、ソルビタン脂肪酸エステル、プロピレングリコール脂肪酸エステル、アラビアガム、カラギーナン、カゼイン、ゼラチン、ペクチン、寒天、ビタミンB類、ニコチン酸アミド、パントテン酸カルシウム、アミノ酸類、カルシウム塩類、色素、香料、保存剤等の食品素材を使用することができる。さらに、健康維持機能をもった本抗疲労用組成物には、他の抗酸化物質や健康食品素材などの配剤、例えば、抗酸化物質(還元型アスコルビン酸(ビタミンC)、ビタミンE、還元型グルタチン、トコトリエノール、ビタミンA誘導体、リコピン、ルテイン、アスタキサンチン、ゼアキサンチン、フコキサンチン、尿酸、ユビキノン、コエンザイムQ10、葉酸、ニンニクエキス、アリシン、セサミン、リグナン類、カテキン、イソフラボン、カルコン、タンニン類、フラボノイド類、クマリン、イソクマリン類、ブルーベリーエキス)、健康食品素材(V.(ビタミン)A、V.B1、V.B2、V.B6、V.B12、V.C、V.D、V.E、V.P、コリン、ナイアシン、パントテン酸、葉酸カルシウム、EPA、オリゴ糖、食物繊維、スクアレン、大豆レシチン、タウリン、ドナリエラ、プロテイン、オクタコサノール、DHA、卵黄レシチン、リノール酸、ラクトフェリン、マグネシウム、亜鉛、クロム、セレン
、カリウム、ヘム鉄、カキ肉エキス、キトサン、キチンオリゴ糖、コラーゲン、コンドロイチン、ウコン、カンゾウ、クコシ、ケイヒ、サンザシ、生姜、霊芝、シジミエキス、スッポン、カンゾウ、クコシ、ケイヒ、サンザシ、生姜、霊芝、オオバコ、カミツレ、カモミール、セイヨウタンポポ、ハイビスカス、ハチミツ、ボーレン、ローヤルゼリー、ライム、ラベンダー、ローズヒップ
、ローズマリー、セージ、ビフィズス菌、フェーカリス菌、ラクリス、小麦胚芽油、ゴマ油、シソ油、大豆油、中鎖脂肪酸、アガリクス、イチョウ葉エキス、ウコン、コンドロイチン、玄米胚芽エキス、レイシ、タマネギ、DHA、 EPA、 DPA、 甜茶、冬虫夏草、ニンニク、蜂の子、パパイヤ、プーアル、プロポリス、メグスリの木、ヤブシタケ、ロイヤルゼリー、ノコギリヤシ、ヒアルロン酸、コラーゲン、ギャバ、ハープシールオイル、サメ軟骨、グルコサミン、レシチン、ホスファチジルセリン、田七ニンジン、桑葉、大豆抽出物、エキナセア、エゾウコギ、大麦抽出物、オリーブ葉、オリーブ実、ギムネマ、バナバ、サラシア、ガルシニア、キトサン、セントジョーンズワート、ナツメ、ニンジン、パッションフラワー、ブロッコリー、プラセンタ、ハトムギ、ブドウ種子、ピーナッツ種皮、ビルベリー、ブラックコホシュ、マリアアザミ、月桂樹、セージ、ローズマリー、ラフマ、黒酢、ゴーヤー、マカ、紅花、亜麻、ウーロン茶、花棘、カフェイン、カプサイシン、キシロオリゴ糖、グルコサミン、ソバ、シトラス、食物繊維、プロテイン、プルーン、スピルリナ、大麦若葉、核酸、酵母、椎茸、梅肉、アミノ酸、深海鮫抽出物、ノニ、カキ肉、スッポン、シャンピニオン、オオバコ、アセロラ、パイナップル、バナナ、モモ、アンズ、メロン、イチゴ、ラズベリー、オレンジ、フコイダン、メシマコブ、クランベリー、コンドロイチン硫酸、亜鉛、鉄、セラミド、シルクペプチド、グリシン、ナイアシン、チェストツリー、L-システイン、赤ワイン葉、ミレット、ホーステール、ビオチン、センテラアジアティカ、ハスカップ、ピクノジェノール、フキ、ルバーブ、クローブ、ローズマリー、カテキン、プーアル、クエン酸、ビール酵母、メリロート、ブラックジンガー、ショウガ、ガジュツ、ナットウキナーゼ、ベニコウジ、トコトリエノール、ラクトフェリン、シナモン、韃靼ソバ、ココア、ユズ種子エキス、シソの実エキス、ライチ種子エキス、月見草エキス、黒米エキス、α−リポ酸、生コーヒー豆エキス)なども配合することができる。
The anti-fatigue composition of the present invention can be used as a material for various foods and drinks. Examples of food and drink include edible oil (salad oil), confectionery (gum, candy, caramel, chocolate, cookie, snack, jelly, gummy, tablet confection etc.), noodles (soba, udon, ramen etc.), dairy products ( Milk, ice cream, yogurt, etc.), seasonings (miso, soy sauce, etc.), soups, beverages (juice, coffee, tea, tea, carbonated drinks, sports drinks, etc.) and health foods (tablets , Capsules, etc.) and nutritional supplements (nutrient drinks, etc.). The anti-fatigue composition of the present invention may be appropriately blended with these foods and drinks.
These foods and drinks can be blended with various components depending on the type, for example, glucose, fructose, sucrose, maltose, sorbitol, stevioside, corn syrup, lactose, citric acid, tartaric acid, malic acid, succinic acid. Acid, lactic acid, L-ascorbic acid, dl-α-tocopherol, sodium erythorbate, glycerin, propylene glycol, glycerin fatty acid ester, polyglycerin fatty acid ester, sucrose fatty acid ester, sorbitan fatty acid ester, propylene glycol fatty acid ester, gum arabic, Food materials such as carrageenan, casein, gelatin, pectin, agar, vitamin Bs, nicotinic acid amide, calcium pantothenate, amino acids, calcium salts, pigments, fragrances and preservatives can be used. In addition, the anti-fatigue composition having a health maintenance function includes other antioxidants and health food ingredients such as antioxidants (reduced ascorbic acid (vitamin C), vitamin E, reduced form). Glutatin, tocotrienol, vitamin A derivative, lycopene, lutein, astaxanthin, zeaxanthin, fucoxanthin, uric acid, ubiquinone, coenzyme Q10, folic acid, garlic extract, allicin, sesamin, lignans, catechin, isoflavone, chalcone, tannins, flavonoids, Coumarin, isocoumarins, blueberry extract), health food ingredients (V. (vitamin) A, V.B1, V.B2, V.B6, V.B12, VC, VD, VE, VP, choline, niacin, pantothenic acid , Calcium folate, EPA, oligosaccharide, dietary fiber, squalene, soy lecithin, taurine, donariella Rotein, octacosanol, DHA, egg yolk lecithin, linoleic acid, lactoferrin, magnesium, zinc, chromium, selenium, potassium, heme iron, oyster meat extract, chitosan, chitin oligosaccharide, collagen, chondroitin, turmeric, licorice, kokushi, keihi, hawthorn , Ginger, ganoderma, swordfish extract, suppon, licorice, kokushi, keihi, hawthorn, ginger, ganoderma, plantain, chamomile, chamomile, dandelion, hibiscus, honey, boren, royal jelly, lime, lavender, rosehip, rosemary, Sage, bifidobacteria, faecalis, lacris, wheat germ oil, sesame oil, perilla oil, soybean oil, medium chain fatty acid, agaricus, ginkgo biloba extract, turmeric, chondroitin, brown rice germ extract, litchi, onion, DHA, EPA, DP A, green tea, cordyceps, garlic, bee, papaya, puer, propolis, meguri tree, yabushitake, royal jelly, saw palmetto, hyaluronic acid, collagen, gabba, harpseal oil, shark cartilage, glucosamine, lecithin, phosphatidylserine, Tanachi Carrot, Mulberry Leaf, Soybean Extract, Echinacea, Ezoukogi, Barley Extract, Olive Leaf, Olive Seed, Gymnema, Banaba, Salacia, Garcinia, Chitosan, St. John's Wort, Jujube, Carrot, Passion Flower, Broccoli, Placenta, Barley , Grape seed, peanut seed coat, bilberry, black cohosh, maria thistle, laurel, sage, rosemary, raffma, black vinegar, bitter gourd, maca, safflower, flax, oolong tea, flower spine, caffeine, capsaicin, ki Looligosaccharide, Glucosamine, Buckwheat, Citrus, Dietary fiber, Protein, Prune, Spirulina, Barley young leaf, Nucleic acid, Yeast, Shiitake, Plum meat, Amino acid, Deep-sea cocoon extract, Noni, Oyster meat, Suppon, Champignon, Psyllium, Acerola, Pineapple, Banana, Peach, Apricot, Melon, Strawberry, Raspberry, Orange, Fucoidan, Meshimakobu, Cranberry, Chondroitin sulfate, Zinc, Iron, Ceramide, Silk peptide, Glycine, Niacin, Chesttree, L-cysteine, Red wine leaf, Millet, Horsetail, Biotin, Centella Asiatica, Lotus Cup, Pycnogenol, Japanese cypress, Rhubarb, Clove, Rosemary, Catechin, Pual, Citric Acid, Beer Yeast, Merirot, Black Zinger, Ginger, Gajutsu, Nattokina Zeo, Benikouji, Tocotrienol, Lactoferrin, Cinnamon, Persimmon Buckwheat, Cocoa, Yuzu Seed Extract, Perilla Seed Extract, Lychee Seed Extract, Evening Primrose Extract, Black Rice Extract, α-Lipoic Acid, Raw Coffee Bean Extract) it can.
具体的な製法としては、抗疲労用組成物を粉末セルロースとともにスプレードライまたは凍結乾燥し、これを粉末、顆粒、打錠または溶液にすることで容易に飲食品(インスタント食品等)に含有させることができる。また、抗疲労用組成物を、例えば、油脂、エタノール、グリセリンあるいはこれらの混合物に溶解して液状にし、飲料に添加するか、固形食品に添加することが可能である。必要に応じてアラビアガム、デキストリン等のバインダーと混合して粉末状あるいは顆粒状にし、飲料に添加するか固形食品に添加することも可能である。
本発明の抗疲労用組成物を飲食品に適用する場合の添加量としては、美容や健康を維持することが主な目的であるので、飲食品に対して有効成分の含量が合計1〜20wt%であるのが好ましい。
As a specific production method, the anti-fatigue composition is spray-dried or freeze-dried together with powdered cellulose, and this is easily incorporated into foods and drinks (instant foods, etc.) by making it into powders, granules, tablets or solutions. Can do. Further, the anti-fatigue composition can be dissolved in, for example, fats and oils, ethanol, glycerin, or a mixture thereof to form a liquid and added to a beverage or added to a solid food. If necessary, it can be mixed with a binder such as gum arabic or dextrin to form a powder or granules and added to a beverage or a solid food.
When the anti-fatigue composition of the present invention is applied to foods and drinks, the main purpose is to maintain beauty and health, so the total content of active ingredients is 1 to 20 wt. % Is preferred.
本発明の抗疲労用組成物は、薬品(医薬品および医薬部外品を含む。)の素材として用いてもよい。薬品製剤用の原料に、本発明の抗疲労用組成物を適宜配合して製造することができる。本発明の抗疲労用組成物に配合しうる製剤原料としては、例えば、賦形剤(ブドウ糖、乳糖、白糖、塩化ナトリウム、デンプン、炭酸カルシウム、カオリン、結晶セルロース、カカオ脂、硬化植物油、カオリン、タルク等)、結合剤(蒸留水、生理食塩水、エタノール水、単シロップ、ブドウ糖液、デンプン液、ゼラチン溶液、カルボキシメチルセルロース、リン酸カリウム、ポリビニルピロリドン等)、崩壊剤(アルギン酸ナトリウム、カンテン、炭酸水素ナトリウム、炭酸カルシウム、ラウリル硫酸ナトリウム、ステアリン酸モノグリセリド、デンプン、乳糖、アラビアゴム末、ゼラチン、エタノール等)、崩壊抑制剤(白糖、ステアリン、カカオ脂、水素添加油等)、吸収促進剤(第四級アンモニウム塩基、ラウリル硫酸ナトリウム等)、吸着剤(グリセリン、デンプン、乳糖、カオリン、ベントナイト、硅酸等)、滑沢剤(精製タルク、ステアリン酸塩、ポリエチレングリコール等)などが挙げられる。 The anti-fatigue composition of the present invention may be used as a raw material for medicines (including pharmaceuticals and quasi drugs). It can be produced by appropriately blending the anti-fatigue composition of the present invention with a raw material for a pharmaceutical preparation. Examples of the pharmaceutical raw material that can be blended in the anti-fatigue composition of the present invention include excipients (glucose, lactose, sucrose, sodium chloride, starch, calcium carbonate, kaolin, crystalline cellulose, cocoa butter, hydrogenated vegetable oil, kaolin, Talc, etc.), binder (distilled water, physiological saline, ethanol water, simple syrup, glucose solution, starch solution, gelatin solution, carboxymethylcellulose, potassium phosphate, polyvinylpyrrolidone, etc.), disintegrant (sodium alginate, agar, carbonate) Sodium hydride, calcium carbonate, sodium lauryl sulfate, stearic acid monoglyceride, starch, lactose, gum arabic powder, gelatin, ethanol, etc.), disintegration inhibitors (sucrose, stearin, cocoa butter, hydrogenated oil, etc.), absorption enhancers (No. Quaternary ammonium base, sodium lauryl sulfate, etc. , Adsorbent (glycerin, starch, lactose, kaolin, bentonite, silicic acid, etc.), lubricants (purified talc, stearates, polyethylene glycol, and the like) and the like.
本発明による抗疲労用組成物の投与方法は、一般的には、錠剤、丸剤、軟・硬カプセル剤、細粒剤、散剤、顆粒剤、液剤等の形態で経口投与することができるが、非経口投与であってもよい。非経口剤として投与する場合は、溶液の状態、または分散剤、懸濁剤、安定剤などを添加した状態で、ハップ剤、ローション剤、軟膏剤、チンキ剤、クリーム剤などの剤形で適用することができる。
投与量は、投与方法、病状、患者の年齢等によって変化し得るが、大人では、通常、1日当たり有効成分として0.5〜1000mg、子供では通常0.5〜500mg程度投与することができる。
抗疲労用組成物の配合比は、剤型によって適宜変更することが可能であるが、通常、経口または粘膜吸収により投与される場合は約0.3〜15.0wt%、非経口投与による場合は、0.01〜10wt%程度にするとよい。なお、投与量は種々の条件で異なるので、前記投与量より少ない量で十分な場合もあるし、また、範囲を超えて投与する必要のある場合もある。
The administration method of the anti-fatigue composition according to the present invention can generally be administered orally in the form of tablets, pills, soft / hard capsules, fine granules, powders, granules, liquids and the like. It may be administered parenterally. When administered as a parenteral agent, it can be applied in the form of a solution, or in the form of a haptic agent, lotion agent, ointment, tincture, cream, etc. with the addition of a dispersant, suspension, stabilizer, etc. can do.
The dosage may vary depending on the administration method, medical condition, age of patient, etc., but for adults, it can be generally administered as 0.5 to 1000 mg as an active ingredient per day, and for children, about 0.5 to 500 mg can be usually administered.
The compounding ratio of the anti-fatigue composition can be appropriately changed depending on the dosage form, but is usually about 0.3 to 15.0 wt% when administered orally or by mucosal absorption, when administered parenterally. Is preferably about 0.01 to 10 wt%. In addition, since the dose varies depending on various conditions, a dose smaller than the above dose may be sufficient, or it may be necessary to administer beyond the range.
実施例:抗疲労用組成物(米抽出物)の製造
実施例1
胚芽米は、ササニシキ米を通常の精米機(例えば柳沢製作所製、RMA-150等)で精米し、糠を除去し、次いで、この胚芽米をさらに研削式精米機(例えば佐竹製作所製、TM5等)で研削した後、適当なふるい(32メッシュ位)で胚乳部由来の粉および糠から、米胚芽を分け取った。
Example: Production of anti-fatigue composition (rice extract) Example 1
For germinated rice, sasanishiki rice is polished with a normal rice mill (for example, RMA-150 manufactured by Yanagisawa Seisakusho) to remove the koji, and then the germinated rice is further grounded by a grinding rice mill (for example, Satake Seisakusho, TM5 etc. ), And then the rice germ was separated from the endosperm-derived powder and straw using a suitable sieve (about 32 mesh).
上記方法により調製した原料米胚芽200gに69℃(還流温度)の温度条件で2時間撹拌後、脂質を抽出分離する操作を1回行った。 抽出後、脱脂胚芽を濾過しn-ヘキサンを取り除いた。次いで、得られた脱脂胚芽0.5gにpH5.6に調整した水8mlを加え、40℃で100ストローク/分にて4時間振盪し、γ−アミノ酪酸を富化した米胚芽を得た。
その後、γ−アミノ酪酸富化米胚芽をさらに水抽出を行い、濃縮殺菌し噴霧乾燥をしたものを米抽出物(実施例1)とした。
After 200 g of raw rice germ prepared by the above method was stirred for 2 hours at 69 ° C. (reflux temperature), the lipid was extracted and separated once. After extraction, the defatted germ was filtered to remove n-hexane. Next, 8 ml of water adjusted to pH 5.6 was added to 0.5 g of the defatted germ obtained, and the mixture was shaken at 40 ° C. at 100 strokes / minute for 4 hours to obtain rice germ enriched in γ-aminobutyric acid.
Thereafter, the rice extract (Example 1) was obtained by subjecting the rice germ enriched with γ-aminobutyric acid to water extraction, concentration sterilization, and spray drying.
実施例2
胚芽米は、ササニシキ米を通常の精米機(例えば柳沢製作所製、RMA-150等)で精米し、糠を除去し、次いで、この胚芽米をさらに研削式精米機(例えば佐竹製作所製、TM5等)で研削した後、適当なふるい(32メッシュ位)で胚乳部由来の粉および糠から、米胚芽を分け取った。
Example 2
For germinated rice, sasanishiki rice is polished with a normal rice mill (for example, RMA-150 manufactured by Yanagisawa Seisakusho) to remove the koji, and then the germinated rice is further grounded by a grinding rice mill (for example, Satake Seisakusho, TM5 etc. ), And then the rice germ was separated from the endosperm-derived powder and straw using a suitable sieve (about 32 mesh).
上記方法により調製した原料米胚芽200gに69℃(還流温度)の温度条件で2時間撹拌後、脂質を抽出分離する操作を1回行った。 抽出後、脱脂胚芽を濾過しn-ヘキサンを取り除いた。次いで、得られた脱脂胚芽0.5gにpH5.6に調整した水8mlを加え、40℃で100ストローク/分にて4時間振盪し、γ−アミノ酪酸を富化した米胚芽を得た。
その後、上記米胚芽にグルタミン酸を加え、乳酸菌にて発酵させ、γ−アミノ酪酸を更に富化させた。その後、γ−アミノ酪酸富化米胚芽をさらに水抽出を行い、濃縮殺菌し噴霧乾燥をしたものを米抽出物(実施例2)とした。
上記実施例1及び実施例2のγ−アミノ酪酸及びその他の成分の含有量は、下記表1に記載されたとおりである。
After 200 g of raw rice germ prepared by the above method was stirred for 2 hours at 69 ° C. (reflux temperature), the lipid was extracted and separated once. After extraction, the defatted germ was filtered to remove n-hexane. Next, 8 ml of water adjusted to pH 5.6 was added to 0.5 g of the defatted germ obtained, and the mixture was shaken at 40 ° C. at 100 strokes / minute for 4 hours to obtain rice germ enriched in γ-aminobutyric acid.
Thereafter, glutamic acid was added to the rice germ and fermented with lactic acid bacteria to further enrich γ-aminobutyric acid. Thereafter, the rice germ enriched in γ-aminobutyric acid was further extracted with water, concentrated, sterilized and spray-dried to obtain a rice extract (Example 2).
The contents of γ-aminobutyric acid and other components of Example 1 and Example 2 are as described in Table 1 below.
試験例:実施例の抗疲労機能の評価
1.精神的疲労誘発試薬の調製
レセルピン(和光純薬工業製、以下、単にRSPともいう。)1.5 mgを秤り取り氷酢酸10mLに溶解させ、蒸留水にて希釈して10mLとした(以下、本明細書では、「精神的疲労誘発試薬」とする。)。
尚、control群に投与するサンプルとして氷酢酸10mLを蒸留水にて希釈して10mLとしたものを調製した(以下、本明細書では、「control試薬」とする。)。
Test example: Evaluation of anti-fatigue function of Examples Preparation of mental fatigue-inducing reagent Reserpine (Wako Pure Chemical Industries, Ltd., hereinafter also referred to simply as RSP) 1.5 mg was weighed and dissolved in 10 mL of glacial acetic acid and diluted to 10 mL with distilled water (hereinafter referred to as “this”). In the description, it is referred to as “mental fatigue inducing reagent”).
A sample to be administered to the control group was prepared by diluting 10 mL of glacial acetic acid with distilled water to 10 mL (hereinafter referred to as “control reagent” in this specification).
2.投与サンプルの調整
50mgの実施例1の米抽出物を蒸留水10 mLに溶解したものを調整した(以下、本明細書では、「実施例1−1サンプル」とする。)。
同様にして、100mgの実施例1の米抽出物を蒸留水10 mLに溶解したものを調整した(以下、本明細書では、「実施例1−2サンプル」とする。)。
また、50mgの実施例2の米抽出物を蒸留水10 mLに溶解したものを調整した(以下、本明細書では、「実施例2−1サンプル」とする。)。
100mgの実施例2の米抽出物を蒸留水10 mLに溶解したものを調整した(以下、本明細書では、「実施例2−2サンプル」とする。)。
尚、比較例として協和発酵製の純品のGABAを蒸留水10 mLに溶解したもの(以下、本明細書では、「純品GABAサンプル」とする。)、及びカフェイン(和光純薬製)を蒸留水10 mLに溶解したもの(以下、「カフェインサンプル」とする)を調製した。
2. Preparation of administration sample
50 mg of the rice extract of Example 1 dissolved in 10 mL of distilled water was prepared (hereinafter referred to as “Example 1-1 sample” in this specification).
Similarly, 100 mg of the rice extract of Example 1 dissolved in 10 mL of distilled water was prepared (hereinafter referred to as “Example 1-2 sample” in this specification).
Further, 50 mg of the rice extract of Example 2 dissolved in 10 mL of distilled water was prepared (hereinafter referred to as “Example 2-1 sample” in this specification).
100 mg of the rice extract of Example 2 dissolved in 10 mL of distilled water was prepared (hereinafter referred to as “Example 2-2 sample” in this specification).
For comparison, pure GABA manufactured by Kyowa Hakko was dissolved in 10 mL of distilled water (hereinafter referred to as “pure GABA sample” in this specification), and caffeine (manufactured by Wako Pure Chemical). Was dissolved in 10 mL of distilled water (hereinafter referred to as “caffeine sample”).
3.群わけ
群わけは、以下のとおりとした。
(1)Control群
(2)比較例1群:RSP群
(3)実施例1−1群:RSPおよび実施例1を50 mg/kg投与
(4)実施例1−2群:RSPおよび実施例1を100 mg/kg投与
(5)実施例2−1群:RSPおよび実施例2を50 mg/kg投与
(6)実施例2−2群:RSPおよび実施例1を100 mg/kg投与
(7)比較例2群:100 mg:RSPおよび純品GABAを50 mg/kg投与
(8)比較例3群:RSPおよびカフェインを50 mg/kg投与
3. The grouping was made as follows.
(1) Control group (2) Comparative example 1 group: RSP group (3) Example 1-1 group: RSP and Example 1 were administered at 50 mg / kg (4) Example 1-2 group: RSP and Example (1) 100 mg / kg administration (5) Example 2-1 group: RSP and Example 2
4.試験方法
実施例1−1群
まず、マウスに上記精神的疲労誘発試薬(1.5 mg/kg)を皮下注射し,精神的疲労を誘発した。その24時間後に上記実施例1−1サンプルを0.1mL経口投与した。
さらに24時間後に、上記実施例1−1経口投与した。1時間後,10分間の強制水泳を施し,その間の不動時間を測定することで疲労回復の程度を評価した。
実施例1−2群
投与サンプルとして、上記実施例1−2サンプルを使用したこと以外、同じ方法にて行った。
実施例2−1群
投与サンプルとして、上記実施例2−1サンプルを使用したこと以外、同じ方法にて行った。
実施例2−2群
投与サンプルとして、上記実施例2−2サンプルを使用したこと以外、同じ方法にて行った。
Control群
先ず、マウスに上記Contro試薬(1.5 mg/kg)を皮下注射した。その24時間後に蒸留水を0.1mL経口投与した。
さらに24時間後に、蒸留水を経口投与した。1時間後,10分間の強制水泳を施し,その間の不動時間を測定することで疲労回復の程度を評価した。
比較例1群
先ず、マウスに上記精神的疲労誘発試薬(1.5 mg/kg)を皮下注射した。その24時間後に蒸留水を0.1mL経口投与した。
さらに24時間後に、蒸留水を経口投与した。1時間後,10分間の強制水泳を施し,その間の不動時間を測定することで疲労回復の程度を評価した。
1時間後,10分間の強制水泳を施し,その間の不動時間を測定することで疲労回復の程度を評価した。
比較例2群
先ず、マウスに上記精神的疲労誘発試薬(1.5 mg/kg)を皮下注射した。その24時間後に純品GABAサンプルを0.1mL経口投与した。
さらに24時間後に、上記純品GABAサンプルを経口投与した。1時間後,10分間の強制水泳を施し,その間の不動時間を測定することで疲労回復の程度を評価した。
1時間後,10分間の強制水泳を施し,その間の不動時間を測定することで疲労回復の程度を評価した。
比較例3群
先ず、マウスに上記精神的疲労誘発試薬(1.5 mg/kg)を皮下注射した。その24時間後に上記カフェインサンプルを0.1mL経口投与した。
さらに24時間後に、上記カフェインサンプルを経口投与した。1時間後,10分間の強制水泳を施し,その間の不動時間を測定することで疲労回復の程度を評価した。
上記各群の試験の結果を図1に示す。
4). Test Method Example 1-1 Group First, the mental fatigue inducing reagent (1.5 mg / kg) was subcutaneously injected into mice to induce mental fatigue. 24 hours later, 0.1 mL of the above Example 1-1 sample was orally administered.
Further 24 hours later, Example 1-1 was orally administered. One hour later, forced swimming was performed for 10 minutes, and the degree of recovery from fatigue was evaluated by measuring the immobility time.
Example 1-2 group It carried out by the same method except having used the said Example 1-2 sample as an administration sample.
Example 2-1 group It carried out by the same method except having used the said Example 2-1 sample as an administration sample.
Example 2-2 group It carried out by the same method except having used the said Example 2-2 sample as an administration sample.
Control group First, mice were subcutaneously injected with the Contro reagent (1.5 mg / kg). 24 hours later, 0.1 mL of distilled water was orally administered.
After another 24 hours, distilled water was orally administered. One hour later, forced swimming was performed for 10 minutes, and the degree of recovery from fatigue was evaluated by measuring the immobility time.
Comparative Example 1 Group First, mice were injected subcutaneously with the mental fatigue inducing reagent (1.5 mg / kg). 24 hours later, 0.1 mL of distilled water was orally administered.
After another 24 hours, distilled water was orally administered. One hour later, forced swimming was performed for 10 minutes, and the degree of recovery from fatigue was evaluated by measuring the immobility time.
One hour later, forced swimming was performed for 10 minutes, and the degree of recovery from fatigue was evaluated by measuring the immobility time.
Comparative Example 2 Group First, mice were subcutaneously injected with the above mental fatigue inducing reagent (1.5 mg / kg). After 24 hours, 0.1 mL of a pure GABA sample was orally administered.
Further 24 hours later, the pure GABA sample was orally administered. One hour later, forced swimming was performed for 10 minutes, and the degree of recovery from fatigue was evaluated by measuring the immobility time.
One hour later, forced swimming was performed for 10 minutes, and the degree of recovery from fatigue was evaluated by measuring the immobility time.
Comparative Example 3 Group First, mice were injected subcutaneously with the above mental fatigue inducing reagent (1.5 mg / kg). 24 hours later, 0.1 mL of the above caffeine sample was orally administered.
After another 24 hours, the caffeine sample was orally administered. One hour later, forced swimming was performed for 10 minutes, and the degree of recovery from fatigue was evaluated by measuring the immobility time.
The results of the tests for each group are shown in FIG.
試験結果
図1によれば、Controlと比較して、比較例1のほうが不動時間が長くなっている。これにより、RSPの投与により不動時間は長くなり,精神的疲労状態が誘発されていることが確認された。
更に、図1によれば、比較例1と比較して実施例1−1、実施例1−2、実施例2−1、実施例2−2の方が、有意に不動時間が短くなっていることがわかる(比較例1:424.1秒、実施例1−1:373.8秒、実施例1−2:335.6秒、実施例2−1:382.9秒、実施例2−2:385秒)。これにより、実施例1及び実施例2の米抽出物には、精神的疲労を軽減する機能を有することが判る。
また、純品GABAサンプルを投与した比較例2(404.9秒)よりも、実施例1−1、実施例1−2、実施例2−1、実施例2−2の方が有意に不動時間が短くなっていることが判る。これにより、純品のγ−アミノ酪酸(比較例2)よりも、γ−アミノ酪酸を含有する米抽出物(実施例1、2)の方が精神的疲労を軽減する機能を有することが判る。
また、実施例1−1(実施例1:50mgサンプル)よりも実施例1−2(実施例1:100mgサンプル)の方が不動時間が短いことが判る。これにより、RSP投与により精神的疲労を誘発したマウスに実施例1の米抽出物を投与することで,濃度依存的に不動時間が短縮されることが判る。上記実施例1の米抽出物は、濃度依存的に精神的疲労を軽減する機能を有することが判る。
更に、純品GABAサンプルを投与した比較例2(404.9秒)よりも、実施例1−1、実施例1−2、実施例2−1、実施例2−2の方が不動時間が短くなっていることが判る。これにより、純品のγ−アミノ酪酸(比較例2)よりも、γ−アミノ酪酸を含有する米抽出物(実施例1、2)の方が精神的疲労を軽減する機能を有することが確認された。γ−アミノ酪酸と米由来の成分(たんぱく質、脂質、糖質等)との両方を含有することにより精神的疲労をより軽減することができることが判る。
Test Results According to FIG. 1, the immobility time is longer in Comparative Example 1 than in Control. As a result, it was confirmed that the immobility time was prolonged by the administration of RSP, and mental fatigue was induced.
Furthermore, according to FIG. 1, compared with the comparative example 1, the immobility time is significantly shorter in the example 1-1, the example 1-2, the example 2-1, and the example 2-2. (Comparative Example 1: 424.1 seconds, Example 1-1: 373.8 seconds, Example 1-2: 335.6 seconds, Example 2-1: 382.9 seconds, Example 2-2: 385 seconds). Thereby, it turns out that the rice extract of Example 1 and Example 2 has the function to reduce mental fatigue.
In addition, compared to Comparative Example 2 (404.9 seconds) in which a pure GABA sample was administered, Example 1-1, Example 1-2, Example 2-1 and Example 2-2 were significantly more immobile. You can see that it is getting shorter. Thereby, it turns out that the rice extract (Examples 1 and 2) containing (gamma) -aminobutyric acid has the function to reduce mental fatigue rather than pure (gamma) -aminobutyric acid (comparative example 2). .
It can also be seen that the immobility time is shorter in Example 1-2 (Example 1: 100 mg sample) than in Example 1-1 (Example 1: 50 mg sample). Thus, it can be seen that the immobility time is shortened in a concentration-dependent manner by administering the rice extract of Example 1 to mice in which mental fatigue has been induced by RSP administration. It can be seen that the rice extract of Example 1 has a function of reducing mental fatigue in a concentration-dependent manner.
Furthermore, the immobility time is shorter in Example 1-1, Example 1-2, Example 2-1, and Example 2-2 than in Comparative Example 2 (404.9 seconds) in which a pure GABA sample was administered. You can see that Thereby, it is confirmed that the rice extract (Examples 1 and 2) containing γ-aminobutyric acid has a function of reducing mental fatigue than the pure γ-aminobutyric acid (Comparative Example 2). It was done. It can be seen that mental fatigue can be further reduced by containing both γ-aminobutyric acid and rice-derived components (proteins, lipids, carbohydrates, etc.).
更に、図1によれば、実施例2を投与した場合と比較して、実施例1を投与したほうが、不動時間が短くなっている。これにより、適度の量のγ−アミノ酪酸及び米由来の成分(ペプチド類、脂質、糖質等)を含有することにより精神的疲労をより軽減することができる。
尚、比較例3(カフェインサンプル投与)においても不動時間は有意に減少し、比較例1と比較すると約125秒短縮され、コントロールと同程度まで短縮された。しかし、上記カフェインサンプルを投与したマウスは、投与した後に、興奮したような異常な動きをした。これにより、上記不動時間短縮の効果は疲労回復というよりも、カフェインの興奮作用により不動時間が短縮されたと考えられる。
Furthermore, according to FIG. 1, the immobility time is shorter when Example 1 is administered than when Example 2 is administered. Thereby, mental fatigue can be further reduced by containing moderate amounts of γ-aminobutyric acid and rice-derived components (peptides, lipids, carbohydrates, etc.).
In Comparative Example 3 (administration of caffeine sample), the immobility time was significantly reduced, which was shortened by about 125 seconds as compared with Comparative Example 1, and was shortened to the same level as that of the control. However, the mice administered with the caffeine sample moved abnormally as if excited after administration. Thus, it is considered that the immobility time was shortened by the excitatory action of caffeine rather than the fatigue recovery.
[配合例]
本発明による抗疲労用組成物の配合例を示す。尚、抗疲労用組成物の配合は下記配合例に限定されない。
配合例1:チューインガム
砂糖 53.0wt%
ガムベース 20.0
グルコース 10.0
水飴 16.0
香料 0.5
抗疲労用組成物 0.5
100.0wt%
[Composition example]
The compounding example of the composition for anti-fatigue by this invention is shown. The blending of the anti-fatigue composition is not limited to the following blending examples.
Formulation Example 1: Chewing gum
53.0wt% sugar
Gum base 20.0
Glucose 10.0
Minamata 16.0
Fragrance 0.5
Anti-fatigue composition 0.5
100.0wt%
配合例2:グミ
還元水飴 40.0wt%
グラニュー糖 20.0
ブドウ糖 20.0
ゼラチン 4.7
水 9.68
オレンジ果汁 4.0
ユズフレーバー 0.6
色素 0.02
抗疲労用組成物 1.0
100.0wt%
Formulation Example 2: Gummy
Reduced water tank 40.0wt%
Granulated sugar 20.0
Glucose 20.0
Gelatin 4.7
Water 9.68
Orange juice 4.0
Yuzu Flavor 0.6
Dye 0.02
Anti-fatigue composition 1.0
100.0wt%
配合例3:キャンディー
砂糖 50.0wt%
水飴 33.0
水 14.4
有機酸 2.0
香料 0.2
抗疲労用組成物 0.4
100.0wt%
Formulation Example 3: Candy
Sugar 50.0wt%
Minamata 33.0
Water 14.4
Organic acid 2.0
Fragrance 0.2
Anti-fatigue composition 0.4
100.0wt%
配合例4:ヨーグルト(ハード・ソフト)
牛乳 41.5wt%
脱脂粉乳 5.8
砂糖 8.0
寒天 0.15
ゼラチン 0.1
乳酸菌 0.005
抗疲労用組成物 0.4
香料 微量
水 残余
100.0wt%
Formulation Example 4: Yogurt (hard / soft)
Milk 41.5wt%
Nonfat dry milk 5.8
Sugar 8.0
Agar 0.15
Gelatin 0.1
Lactic acid bacteria 0.005
Anti-fatigue composition 0.4
Perfume
Water residue
100.0wt%
配合例5:清涼飲料
果糖ブドウ糖液糖 30.0wt%
乳化剤 0.5
抗疲労用組成物 0.3
香料 適量
精製水 残余
100.0wt%
Formulation Example 5: Soft drink
Fructose glucose liquid sugar 30.0wt%
Emulsifier 0.5
Anti-fatigue composition 0.3
Perfume
Purified water residue
100.0wt%
配合例6:錠菓
砂糖 76.4wt%
グルコース 19.0
ショ糖脂肪酸エステル 0.2
抗疲労用組成物 0.5
精製水 3.9
100.0wt%
Formulation Example 6: Tablets
76.4 wt% sugar
Glucose 19.0
Sucrose fatty acid ester 0.2
Anti-fatigue composition 0.5
Purified water 3.9
100.0wt%
配合例7:ソフトカプセル
玄米胚芽油 47.0wt%
ユズ抽出物 40.0
乳化剤 12.0
抗疲労用組成物 1.0
100.0wt%
Formulation Example 7: Soft capsule
Brown rice germ oil 47.0wt%
Yuzu extract 40.0
Emulsifier 12.0
Anti-fatigue composition 1.0
100.0wt%
配合例8:錠剤
乳糖 54.0wt%
結晶セルロース 30.0
澱粉分解物 10.0
グリセリン脂肪酸エステル 5.0
抗疲労用組成物 1.0
100.0wt%
Formulation Example 8: Tablet
Lactose 54.0wt%
Crystalline cellulose 30.0
Starch degradation product 10.0
Glycerin fatty acid ester 5.0
Anti-fatigue composition 1.0
100.0wt%
配合例7:コーヒー飲料(液状)
焙煎コーヒー豆 6.0wt%
砂糖 6.0
重曹 0.2
乳化剤 0.15
抗疲労用組成物 1.0
水 残余
100.0wt%
Formulation Example 7: Coffee drink (liquid)
Roasted coffee beans 6.0wt%
Sugar 6.0
Baking soda 0.2
Emulsifier 0.15
Anti-fatigue composition 1.0
Water residue
100.0wt%
配合例8:コーヒー飲料(粉末)
インスタントコーヒー 90.0wt%
脱脂乳 7.0
抗疲労用組成物 3.0
100.0wt%
Formulation Example 8: Coffee drink (powder)
Instant coffee 90.0wt%
Skim milk 7.0
Anti-fatigue composition 3.0
100.0wt%
配合例8:チョコレート菓子
チョコレート 95.0wt%
脱脂乳 3.0
砂糖 1.0
抗疲労用組成物 1.0
100.0wt%
Formulation Example 8: Chocolate confectionery
Chocolate 95.0wt%
Nonfat milk 3.0
Sugar 1.0
Anti-fatigue composition 1.0
100.0wt%
以上の説明により、本発明の抗疲労用組成物は、米由来のγ−アミノ酪酸類を含有する米抽出物を有効成分とすることにより、特に精神的疲労を軽減する機能を有し、また、γ−アミノ酪酸類とその他の米由来の成分(ペプチド類、脂質、糖類等)との両方を含有することにより、精神的疲労を更に軽減させることができる。更に、本発明の抗疲労用組成物は、天然の食用植物に由来する組成物であって、副作用がなく長期にわたって摂取できるものである。従って、本発明の抗疲労用組成物は、疲労、特に精神的な疲労を軽減する機能を有し、且つ、安全な食品組成物又は医薬組成物又は化粧品用組成物を提供することができる。 As described above, the anti-fatigue composition of the present invention has a function of particularly reducing mental fatigue by using a rice extract containing γ-aminobutyric acid derived from rice as an active ingredient, By containing both γ-aminobutyric acids and other rice-derived components (peptides, lipids, saccharides, etc.), mental fatigue can be further reduced. Furthermore, the anti-fatigue composition of the present invention is a composition derived from a natural edible plant and has no side effects and can be ingested over a long period of time. Therefore, the anti-fatigue composition of the present invention has a function of reducing fatigue, particularly mental fatigue, and can provide a safe food composition, pharmaceutical composition or cosmetic composition.
Claims (8)
該米抽出物(A)には、米由来のγ−アミノ酪酸類(a−1)を含有することを特徴とする抗疲労用組成物。 Rice germ (A) extracted from at least one of rice germ, rice bran containing germ, germ rice, brown rice, germinated brown rice, and white rice as an active ingredient,
The anti-fatigue composition characterized in that the rice extract (A) contains γ-aminobutyric acid (a-1) derived from rice.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2006051355A JP2007230881A (en) | 2006-02-27 | 2006-02-27 | Anti-fatigue composition |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2006051355A JP2007230881A (en) | 2006-02-27 | 2006-02-27 | Anti-fatigue composition |
Publications (1)
Publication Number | Publication Date |
---|---|
JP2007230881A true JP2007230881A (en) | 2007-09-13 |
Family
ID=38551842
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2006051355A Pending JP2007230881A (en) | 2006-02-27 | 2006-02-27 | Anti-fatigue composition |
Country Status (1)
Country | Link |
---|---|
JP (1) | JP2007230881A (en) |
Cited By (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2009221135A (en) * | 2008-03-14 | 2009-10-01 | Gekkeikan Sake Co Ltd | Fatigue-reducing agent |
JP2012055261A (en) * | 2010-09-10 | 2012-03-22 | Mitsubishi-Kagaku Foods Corp | Production method of soft candy, and soft candy |
JP2013506408A (en) * | 2009-10-02 | 2013-02-28 | ジボダン エス エー | Increasing flavor |
KR20160025808A (en) * | 2014-08-28 | 2016-03-09 | (주)아스터젠 | Composition having effects of preventing or recovering fatigue or stress |
-
2006
- 2006-02-27 JP JP2006051355A patent/JP2007230881A/en active Pending
Cited By (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2009221135A (en) * | 2008-03-14 | 2009-10-01 | Gekkeikan Sake Co Ltd | Fatigue-reducing agent |
JP2013506408A (en) * | 2009-10-02 | 2013-02-28 | ジボダン エス エー | Increasing flavor |
JP2012055261A (en) * | 2010-09-10 | 2012-03-22 | Mitsubishi-Kagaku Foods Corp | Production method of soft candy, and soft candy |
KR20160025808A (en) * | 2014-08-28 | 2016-03-09 | (주)아스터젠 | Composition having effects of preventing or recovering fatigue or stress |
KR101689259B1 (en) * | 2014-08-28 | 2017-01-02 | (주)아스터젠 | Composition having effects of preventing or recovering fatigue or stress |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP2013241354A (en) | Phosphodiesterase 2 inhibitor | |
WO2016163245A1 (en) | Activator of energy metabolism in muscle cells | |
JP6086953B2 (en) | AMPK activator | |
JP7685633B2 (en) | Agents for improving fatigue, loss of motivation, or drowsiness | |
JP2022060571A (en) | Bone fortifier dietary supplements | |
JP2006083151A (en) | Composition for preventing and ameliorating osteoporosis | |
JP2007222116A (en) | Health food and drink | |
JP2010265251A (en) | Blood flow promoting agent | |
JP6085137B2 (en) | Anti-aging agent | |
JP6552097B2 (en) | Bitterness improving agent for food and drink, method for improving bitterness for food and drink, and composition for food and drink | |
JP2016124832A (en) | Energy metabolism activator in muscle cells | |
JP2009269832A (en) | Calcitonin gene-related peptide and composition for accelerating production of insulin-like growth factor-1 | |
JP2007230881A (en) | Anti-fatigue composition | |
JP2017193497A (en) | Muscle-enhancing agent | |
JP7016510B2 (en) | Blood cholesterol elevation inhibitory composition | |
JP2020080803A (en) | Spice, bonito extract and kelp extract-containing composition | |
JP6981641B2 (en) | PDE5 activity inhibitor | |
JP2015063507A (en) | Inhibitor for retinal disorder caused by aging | |
JP6841444B2 (en) | Immunostimulant | |
JP2012006905A (en) | Composition for skin care | |
JP2022079610A (en) | Composition for suppressing increase in triglyceride in blood | |
JP2017031120A (en) | TNF-α AND IL-6 PRODUCTION INHIBITORS, AND MUSCLE INFLAMMATORY INHIBITORS USING THE SAME | |
JP2014141437A (en) | Learning memory improving agent | |
JP4352030B2 (en) | healthy food | |
JP2020015726A (en) | INHIBITORS OF TNF-α AND IL-6 PRODUCTION AND MUSCLE INFLAMMATION INHIBITING AGENTS USING THE SAME |